See personalized New Product recommendations! Get personalized New Product recommendations! Register or Login for personalized New Product recommendations!

Join us! · InformexUSA 2012 · New Orleans, Louisiana · February 14-17, 2012 · Booth 2514

Application · Mass Spectrometry

· See all 100+ product categories

Item Number Product Sizes & Pricing CAS Purity Image Exclusive Introduction Date Mojo Plain Text Name Synonyms Keywords Interest
10007975 (±)11,12-DHET-d11 Exclusive - ≥99% deuterated forms (d1-d11) ✓ 2008-03-17 9.767403314917 -11-12-dhet-d11 (±)11,12-DiHETrE-d11 epoxides epoxygenases DHT hydrolases (+/-)11,12-DiHETrEs deuterated epoxide hydrolase deuterated deuterium 9.767403314917
10007266 (±)11,12-DHET Lipid Maps MS Standard - ≥98% 2009-02-11 52.514077348066 -11-12-dhet-lipid-maps-ms-standard (±)11,12-DiHETrE epoxides epoxygenases DHTs hydrolases (+/-)11,12-DiHETrEs MS mass spectrometry standards 52.514077348066
10006413 (±)11(12)-EET-d11 Exclusive - ≥99% deuterated forms (d1-d11) ✓ 2008-03-25 25.703609576427 -11-12-eet-d11 (±)11(12)-EpETrE-d11 epoxides epoxygenases 11,12-EETs cytochrome P450 (+/-)11,12-EpETrEs (+/-)11(12)-EpETrEs deuterated deuterium 25.703609576427
10007262 (±)11(12)-EET Lipid Maps MS Standard - ≥98% 2009-02-11 19.253825966851 -11-12-eet-lipid-maps-ms-standard (±)11(12)-EpETrE epoxides epoxygenases 11,12-EETs cytochrome P450 (+/-)11,12-EpETrEs (+/-)11(12)-EpETrEs MS mass spectrometry standards 19.253825966851
319500 11-dehydro Thromboxane B2-d4 - ≥99% deuterated product 25.379875690608 11-dehydro-thromboxane-b2-d4 11-keto TXB2-d4 GC/MS deuterium isotopes 11-dh-TXB2-d4 internal standards thromboxanes 11-dehydro-TXB2-d4 deuterated GC-MS LC/MS LC-MS mass spectrometry atherosclerosis 25.379875690608
10007239 11-dehydro Thromboxane B2 Lipid Maps MS Standard 67910-12-7 ≥98% 2009-01-16 14.814704025256 11-dehydro-thromboxane-b2-lipid-maps-ms-standard 11-dehydro TXB2; 11-keto TXB2 metabolites thromboxanes plasma 11-dehydro-TXB2 11-keto-TXB2 atherosclerosis MS mass spectrometry standards 14.814704025256
10006831 11-dehydro Thromboxane B2 Quant-PAK - 2005-08-08 18.654438305709 11-dehydro-thromboxane-b2-quant-pak Quant-PAKs metabolites thromboxanes plasma deuterium isotopes 11-dh-TXB2-d4 internal standards 11-dehydro-TXB2-d4 deuterated GC/MS GC-MS LC/MS LC-MS mass spectrometry atherosclerosis packs 18.654438305709
10009898 (−)-11-nor-9-carboxy-Δ9-THC-d3 (solution) 130381-15-6 ≥99% deuterated forms (d1-d3) 2010-11-12 6.273825966850 -11-nor-9-carboxy-9-thc-d3-solution THC metabolites Delta9-THC Δ9 THC tetrahydrocannabinols marijuana deuterateds deuterium internal standards mass spectrometry GC/MS LC/MS GC-MS LC-MS MS cannabinoids cbs synthetic 10916 6.273825966850
10007246 11(S)-HETE Lipid Maps MS Standard 54886-50-9 ≥98% 2009-02-17 6.909779005524 11-s-hete-lipid-maps-ms-standard hydroxy fatty acids 11-HETEs 11S-HETEs 11(S)-HETEs 11(S)HETEs 11-LOs 11-lipoxygenases MS mass spectrometry standards 6.909779005524
10008989 11β-Prostaglandin F2α-d4 - ≥99% deuterated product 2006-09-15 38.688508287292 11-prostaglandin-f2-d4 GC/MS deuteriums isotopes internal standards deuterated LC/MS GC-MS LC-MS mass spectrometry spectoscopy signalling 11β-PGF2α 11βa-PGF2α metabolites PGD2 prostaglandins 9.beta.-11-deoxy-PGF2α 9beta-11-deoxy-PGF2α 9b-11-deoxy-PGF2alpha 38.688508287292
10007224 11β-Prostaglandin F2α Lipid Maps MS Standard 38432-87-0 >99% 2008-12-11 30.763370165745 11-prostaglandin-f2-lipid-maps-ms-standard 11β-PGF2α 11.beta.-PGF2.alpha. 11beta-PGF2alpha metabolites PGD2 prostaglandins 9.beta.-11-deoxy-PGF2.alpha. 9beta-11-deoxy-PGF2alpha MS Mass spectrometry standards 30.763370165745
10009994 (±)12,13-DiHOME-d4 - ≥99% deuterated forms (d1-d4) 2007-06-26 5.454254143646 -12-13-dihome-d4 Isoleukotoxin diol-d4 epoxides epoxygenase leukotoxin cytochrome P450 CYP450 sEH soluble epoxide hydrolase UGT glucuronidation UGT2B7 mass spectrometry MS deuterated deuterium 5.454254143646
10009996 (±)12(13)-EpOME-d4 - ≥99% deuterated forms (d1-d4) 2007-06-04 2.316795580110 -12-13-epome-d4 iso-Leukotoxin-d4; 12,13-EODE-d4 epoxides epoxygenases cytochrome P450 (+/-)12,13-EpOMEs (+/-)12(13)-EpOMEs epoxy fatty acids 2.316795580110
320135 12-epi Leukotriene B4-d4 - ≥99% deuterated product 92.768434622468 12-epi-leukotriene-b4-d4 12-epi LTB4-d4 12-epi-LTB4-d4 12(S)-LTB4-d4 12(S)LTB4-d4 12S-LTB4-d4 leukotrienes mass spectrometry GC/MS LC/MS GC-MS LC-MS internal standards deuterated deuterium isotopes 92.768434622468
10007249 12-OxoETE Lipid Maps MS Standard 108437-64-5 ≥90% 2009-02-18 25.686675874769 12-oxoete-lipid-maps-ms-standard 12-KETE HETEs metabolites 12-KETEs chemotactic 12-OxoETEs fatty acids oxo-acids 12-oxo-ETEs MS mass spectrometry standards 25.686675874769
10007247 12(R)-HETE Lipid Maps MS Standard 82337-46-0 ≥98% 2009-02-17 20.815497237568 12-r-hete-lipid-maps-ms-standard hydroxy acids 12-LOs sea urchin 12R-HETEs 12-HETEs fatty 12(R)-HETEs 12(R)HETEs 12-lipoxygenases MS mass spectrometry standards 20.815497237568
334570 12(S)-HETE-d8 84807-90-9 ≥99% deuterated product 47.663911602209 12-s-hete-d8 GC/MS deuterium isotopes 12-HETE-d8 standards12S-HETE-d8 deuterated GC-MS LC/MS LC-MS 12-HETEs 12(S)-HETEs 12S-HETEs 12(S)HETEs hydroxy fatty acids 12(S)HETE-d8 mass spectrometry 47.663911602209
10007248 12(S)-HETE Lipid Maps MS Standard 54397-83-0 ≥98% 2009-02-18 28.094574585635 12-s-hete-lipid-maps-ms-standard 12-HETEs 12-LOs pig leukocytes platelets human 12S-HETEs 12-lipoxygenases 12(S)-HETEs porcine hydroxy fatty acids 12(S)HETEs MS mass spectrometry standards 28.094574585635
10007250 12(S)-HHTrE Lipid Maps MS Standard 54397-84-1 ≥97% 2009-02-26 35.295558011050 12-s-hhtre-lipid-maps-ms-standard 12-HHT platelets thromboxanes hydroxy acids 12S-HHTrEs 12-HHTrEs fatty atherosclerosis MS mass spectrometry standards 35.295558011050
10007258 12(S)-HpETE Lipid Maps MS Standard 71774-10-2 ≥98% 2009-02-02 18.024519337017 12-s-hpete-lipid-maps-ms-standard 12-LOs 12-HpETEs 12S-HpETEs hydroperoxides 12-lipoxygenases 12(S)-HpETEs monohydroperoxy fatty arachidonic acids polyunsaturated MS mass spectrometry standard 18.024519337017
10007978 13,14-dihydro-15-keto Prostaglandin D2-d4 - ≥99% deuterated product 2006-02-10 141.153950276243 13-14-dihydro-15-keto-prostaglandin-d2-d4 13,14-dihydro-15-keto PGD2-d4 GC/MS deuteriums isotopes internal standards deuterateds LC/MS GC-MS LC-MS mass spectrometry metabolites 13,14-dihydro-15-keto-PGD2 prostaglandins 141.153950276243
10007208 13,14-dihydro-15-keto Prostaglandin D2 Lipid Maps MS Standard 59894-07-4 >98% 2008-10-29 48.588379373849 13-14-dihydro-15-keto-prostaglandin-d2-lipid-maps-ms-standard 13,14-dihydro-15-keto PGD2 metabolites 13,14-dihydro-15-keto-PGD2 prostaglandins GC LC MS mass spectrometry standards GC/MS LC/MS GC-MS LC-MS 48.588379373849
9000288 13,14-dihydro-15-keto Prostaglandin E1-d4 - ≥99% deuterated product 2004-05-05 51.286110497237 13-14-dihydro-15-keto-prostaglandin-e1-d4 13,14-dh-15-k PGE1-d4 PGE0 metabolites 13,14-dihydro-15-ketoPGE1 prostaglandins deuterium deuterateds 51.286110497237
10010606 13,14-dihydro-15-keto Prostaglandin E2-d4 Exclusive - >99% deuterated product ✓ 2008-03-18 14.858931860037 13-14-dihydro-15-keto-prostaglandin-e2-d4 13,14-dh-15-keto PGE2-d4 deuterated metabolites 13,14-dihydro-15-keto-PGE2 prostaglandins PGE2 deuterium 14.858931860037
10007214 13,14-dihydro-15-keto Prostaglandin E2 Lipid Maps MS Standard 363-23-5 >98% 2008-11-12 42.806883977900 13-14-dihydro-15-keto-prostaglandin-e2-lipid-maps-ms-standard 13,14-dihydro-15-keto PGE2 metabolites 13,14-dihydro-15-keto-PGE2 prostaglandins GC LC MS mass spectrometry standards GC/MS LC/MS GC-MS LC-MS 42.806883977900
10007793 13,14-dihydro-15-keto Prostaglandin F2α-d4 - ≥99% deuterated product 2006-02-06 10.659723756905 13-14-dihydro-15-keto-prostaglandin-f2-d4 PGFM-d4 GC/MS deuteriums isotopes internal standards deuterateds LC/MS GC-MS LC-MS mass spectrometry 13,14-dihydro-15-keto-PGF2a 13,14-dihydro-15-keto-PGF2.alpha. metabolites prostaglandins 10.659723756905
10007226 13,14-dihydro-15-keto Prostaglandin F2α Lipid Maps MS Standard 27376-76-7 >99% 2008-12-04 2.571955801104 13-14-dihydro-15-keto-prostaglandin-f2-lipid-maps-ms-standard 13,14-dihydro-15-keto PGF2α; PGFM; 13,14-dh-15-k PGF2α 13,14-dihydro-15-keto-PGF2alpha 13,14-dihydro-15-keto-PGF2.alpha. metabolites prostaglandins MS mass spectrometry PGs marker plasma 2.571955801104
9000281 13,14-dihydro Prostaglandin E1-d4 - >99% deuterated product 2004-05-06 48.194263351749 13-14-dihydro-prostaglandin-e1-d4 13,14-dh PGE1-d4; Prostaglandin E0-D4 PGE0 metabolites 13,14-dihydro-PGE1 prostaglandins GC/MS deuterium isotopes PGA2-d4 internal standards deuterated LC/MS GC-MS LC-MS mass spectrometry gas liquid chromatography spectroscopy 48.194263351749
338620 13-OxoODE-d3 New - ≥99% deuterated product 2011-11-11 6.663195612138 13-oxoode-d3 13-KODE-d3 13-KODEs fatty metabolites 13-OxoODEs 13-oxo-ODEs oxo-acids deuterateds deuterium mass spectrometry LC-MS LC/MS NAD+ rats colonic cells proliferation oxo-fatty 13-HODEs HODEs NAD dependent dehydrogenase mucosa intra-rectally intrarectally maturation reticulocytes erythrocytes 15-LO 15-lipoxygenase OxoODEs 6.663195612138
338610 13(S)-HODE-d4 139408-39-2 ≥99% deuterated product 39.474696132597 13-s-hode-d4 GC/MS deuterium isotopes 13-HODE-d4 standards 13S-HODE-d4 deuterated GC-MS LC/MS LC-MS 13-HODEs 13(S)-HODEs 13S-HODEs 13(S)HODEs hydroxy fatty acids 13(S)HODE-d4 mass spectrometry 39.474696132597
10008040 (±)14,15-DHET-d11 Exclusive - ≥99% deuterated forms (d1-d11) ✓ 2008-03-18 20.872209944752 -14-15-dhet-d11 (±)14,15-DiHETrE-d11 epoxides epoxygenases DHT hydrolases (+/-)14,15-DiHETrEs deuterated epoxide hydrolase deuterium 20.872209944752
10007267 (±)14,15-DHET Lipid Maps MS Standard - >98% 2009-01-06 18.497085635359 -14-15-dhet-lipid-maps-ms-standard (±)14,15-DiHETrE epoxides epoxygenases DHTs hydrolases (+/-)14,15-DiHETrEs MS mass spectrometry standards 18.497085635359
10006410 (±)14(15)-EET-d11 - ≥99% deuterated forms (d1-d11) 2007-07-22 55.203977900552 -14-15-eet-d11 (±)14(15)-EpETrE-d11 epoxides epoxygenases cytochrome P450 (+/-)14(15)-EpETrEs (+/-)5,6-EpETrEs fatty acids deuterated deuterium CYP450 mass spectrometry MS 14,15-EETs biosynthesized liver microsomes pregnancy hypertension 55.203977900552
10007263 (±)14(15)-EET Lipid Maps MS Standard - ≥98% 2009-02-11 11.008895027623 -14-15-eet-lipid-maps-ms-standard (±)14(15)-EpETrE epoxides epoxygenases 14,15-EETs cytochrome P450 (+/-)14,15-EpETrEs (+/-)14(15)-EpETrEs MS mass spectrometry standards 11.008895027623
318570 15-deoxy-Δ12,14-Prostaglandin J2-d4 - ≥99% deuterated product 45.031193370165 15-deoxy-12-14-prostaglandin-j2-d4 15-deoxy-Δ12,14-PGJ2-d4 GC/MS deuterium isotopes 15-deoxy-DELTA12,14-PGJ2-d4 15-deoxy-.DELTA.12,14-PGJ2-d4 15-deoxy-D12,14-PGJ2-d4 internal standards prostaglandins deuterated mass spectrometry GC-MS LC-MS LC/MS atherosclerosis 45.031193370165
10007235 15-deoxy-Δ12,14-Prostaglandin J2 Lipid Maps MS Standard 87893-55-8 ≥97% 2009-01-16 51.545994475138 15-deoxy-12-14-prostaglandin-j2-lipid-maps-ms-standard 15-deoxy-Δ12,14-PGJ2 PPARγ PPARgamma prostaglandins 15-deoxy-delta12,14-PGJ2 15-deoxy-d12,14-PGJ2 nuclear receptors 15-deoxy-Δ12,14-PGJ2 peroxisome proliferator-activated receptors PPARs activators ligands atherosclerosis MS mass spectrometry standards 51.545994475138
10007215 15-keto Prostaglandin E2 Lipid Maps MS Standard 26441-05-4 >99% 2008-12-15 74.332173112339 15-keto-prostaglandin-e2-lipid-maps-ms-standard 15-keto PGE2 15-keto-PGE2 metabolites prostaglandins MS mass spectrometry standards PGs inactive 74.332173112339
10007227 15-keto Prostaglandin F2α Lipid Maps MS Standard 35850-13-6 >98% 2008-12-18 14.450787292817 15-keto-prostaglandin-f2-lipid-maps-ms-standard 15-keto PGF2α 15-keto-PGF2alpha 15-keto-PGF2.alpha. metabolites prostaglandins endocrinology PGs PGF2α MS Mass Spectrometry 14.450787292817
334720 15(S)-HETE-d8 84807-87-4 ≥99% deuterated product 39.003388581951 15-s-hete-d8 GC/MS deuterium isotopes 15-HETE-d8 standards 15S-HETE-d8 15(S)HETE-d8 deuterated GC-MS LC/MS LC-MS 15-HETEs 15(S)-HETEs 15S-HETEs 15(S)HETEs hydroxy fatty acids mass spectrometry 15HETE 39.003388581951
10007251 15(S)-HETE Lipid Maps MS Standard 54845-95-3 ≥98% 2009-02-17 17.652116447088 15-s-hete-lipid-maps-ms-standard soybean 15-LOs asthma airway 15-lipoxygenases monohydroxy fatty acids 15S-HETES 15-HETES arachidonic 15(S)-HETEs 15(S)HETEs potato polyunsaturated MS mass spectrometry standards 15HETE 17.652116447088
10007259 15(S)-HpETE Lipid Maps MS Standard 70981-96-3 >98% 2009-02-10 10.265856353591 15-s-hpete-lipid-maps-ms-standard 15-LOs 15-HpETEs 15S-HpETEs hydroperoxides 15(S)-HpETEs 15(S)HPETEs 15-lipoxygenases monohydroperoxy fatty arachidonic acids polyunsaturated MS mass spectrometry standards 10.265856353591
316810 17-phenyl trinor Prostaglandin F2α-d4 - ≥99% deuterated product 92.959135359116 17-phenyl-trinor-prostaglandin-f2-d4 17-phenyl trinor PGF2α-d4; Bimatoprost (free acid)-d4 GC/MS deuterium isotopes 17-phenyl-trinor-PGF2.alpha.-3,3,4,4-d4 17-pheny-trinor-PGF2alpha-3,3,4,4-d4 GC-MS LS/MS LC-MS mass spectrometry spectroscopy chromatography deuterateds 92.959135359116
316820 17-phenyl trinor Prostaglandin F2α ethyl amide-d4 - ≥99% deuterated product 101.781568008418 17-phenyl-trinor-prostaglandin-f2-ethyl-amide-d4 17-phenyl trinor PGF2α ethyl amide-d4; Bimatoprost-d4 GC/MS deuterium isotopes 8-isoprostanes 17-phenyl-trinor-PGF2.alpha.-3,3,4,4-d4 17-phenyl-trinor-PGF2alpha-3,3,4,4-d4 GC-MS LS/MS LC-MS mass spectrometry spectroscopy chromatography deuterateds 101.781568008418
10007217 19(R)-hydroxy Prostaglandin E2 Lipid Maps MS Standard 64625-54-3 >98% 2008-12-17 65.798434622467 19-r-hydroxy-prostaglandin-e2-lipid-maps-ms-standard 19(R)-OH PGE2; 19(R)-hydroxy PGE2 19(R)-hydroxy-PGE2 19(R)-OH-PGE2 19R-hydroxy-PGE2 19R-OH-PGE2 metabolites semen agonists EP2 prostaglandins receptors hydroxylated PGs MS mass spectrometry standards 65.798434622467
362152 1-Arachidonoyl Glycerol-d5 - ≥99% deuterated product 29.892113259668 1-arachidonoyl-glycerol-d5 1-AG-d5 deuterium isotopes GC/MS endocannabinoids anandamides 1AG-d5 GC-MS mass spectrometry LC/MS LC-MS deuterated standards 1-AG-d5 internal fatty acids cannabinoids cbs synthetic 29.892113259668
10009431 1-Stearoyl-2-Arachidonoyl PC-d8 Exclusive - 99% deuterated product ✓ 2009-07-24 14.387154696133 1-stearoyl-2-arachidonoyl-pc-d8 SAPC-d8; 1-Stearoyl-2-Arachidonoyl Phosphatidylcholine-d8 SAPC LDL oxidation inflammation cardiovascular disease phospholipids LC/MS GC/MS deuterated deuteriums mass spectrometry MS LC-MS GC-MS standards 14.387154696133
390030 20-HETE-d6 - ≥99% deuterated product 77.450497237569 20-hete-d6 20-hydroxy Arachidonic Acid-d6 CYP450 vasocontriction standards vasoconstrictors GC-MS GC/MS LC-MS LC/MS cytochrome chromatography mass spectroscopy deuterium deuterateds 77.450497237569
10007269 20-HETE Lipid Maps MS Standard 79551-86-3 ≥98% 2009-02-18 22.125657458563 20-hete-lipid-maps-ms-standard 20-hydroxy Arachidonic Acid hydroxy fatty acids omega-oxidation .omega.-oxidation w-oxidation cytochrome P450 CYP450 arachidonic HETEs metabolites P-450 vasoconstrictors vasoconstriction MS mass spectrometry standards 22.125657458563
10007218 20-hydroxy Prostaglandin E2 Lipid Maps MS Standard 57930-95-7 ≥98% 2008-12-15 98.429751381215 20-hydroxy-prostaglandin-e2-lipid-maps-ms-standard 20-hydroxy PGE2 20-hydroxy-PGE2 20-OH-PGE2 metabolites prostaglandins hydroxylated MS mass spectrometry standards PGs intermediates 98.429751381215
10007229 20-hydroxy Prostaglandin F2α Lipid Maps MS Standard 57930-92-4 ≥98% 2009-01-28 14.770423572744 20-hydroxy-prostaglandin-f2-lipid-maps-ms-standard 20-hydroxy PGF2α 20-hydroxy-PGF2alpha 20-hydroxy-PGF2.alpha. prostaglandins hydroxylated 20-OH-PGF2.alpha. 20-OH-PGF2alpha MS mass spectrometry PGs 14.770423572744
10007225 2,3-dinor-11β-Prostaglandin F2α Lipid Maps MS Standard 240405-20-3 >98% 2008-12-17 66.802795580111 2-3-dinor-11-prostaglandin-f2-lipid-maps-ms-standard 2,3-dinor-11β-PGF2α 2,3-dinor-11.beta.-PGF2.alpha. 2,3-dinor-11beta-PGF2alpha 2,3-dinor-11b-PGF2alpha prostaglandins urine PGD2 asthmatic asthma urinary PGs 2,3-dinor-11β-PGF2α MS mass spectrometry standards 66.802795580111
13049 2-(4-Pyridyl)-4-methyl-thiazole-5-Carboxylic Acid 144060-98-0 ≥98% 2009-02-14 0.099401473297 2-4-pyridyl-4-methyl-thiazole-5-carboxylic-acid BR Labs pyrimidines acids intermediates synthetic 0.099401473297
11099 25-hydroxy Cholesterol-d6 New 88247-69-2 ≥99% deuterated form (d1-d6) 2012-01-27 104.017900552485 25-hydroxy-cholesterol-d6 deuterated deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS 16505-96-7 oxysterol cholesterol SREBP sterols regulatory elements binding proteins atherosclerosis anticancer apoptosis immunosuppressive Bcl-2 caspases atherosclerosis antitumor tumors LXR-RXR ligands T cells macrophages 104.017900552485
362162 2-Arachidonoyl Glycerol-d5 - ≥99% deuterated product 46.147099447513 2-arachidonoyl-glycerol-d5 2-AG-d5 deuterium isotopes GC/MS endocannabinoids anandamides 2AG-d5 GC-MS mass spectrometry LC/MS LC-MS deuterated standards 2-AG-d5 internal fatty acids lipids neurochemistry neuroscience endocrinology cannabinoids cbs synthetic 46.147099447513
362160 2-Arachidonoyl Glycerol-d8 - ≥99% deuterated product 71.042030386740 2-arachidonoyl-glycerol-d8 2-AG-d8 deuterium isotopes GC/MS endocannabinoids anandamides 2AG-d8 GC-MS mass spectrometry LC/MS LC-MS deuterated standards internal neurochemistry neuroscience endocrinology cannabinoids cbs synthetic 71.042030386740
10918 (±)3-epi CP 47,497-C8-homolog - ≥98% 2011-05-06 12.267457068203 -3-epi-cp-47-497-c8-homolog (±)-trans-CAY10596 (±)-3-epi CP 47,497-C8 analogs trans-CAY10596 cannabinoids analogs receptors by-product standards (+)-CP 47,497-C8 CB2 CP 47497 CP47497 CP-47497 CP-47,497 cbs synthetic 13802 12.267457068203
13802 (±)3-epi CP 47,497-C8-homolog (solution) Exclusive - ≥98% ✓ 2010-08-04 11.371533840622 -3-epi-cp-47-497-c8-homolog-solution (±)-trans-CAY10596 (±)-3-epi CP 47,497-C8 analogs trans-CAY10596 cannabinoids analogs receptors by-product standards (+)-CP 47,497-C8 CB2 CP 47497 CP47497 CP-47497 CP-47,497 cbs synthetic 10918 11.371533840622
9000368 3-hydroxy-3-methylglutaryl-Coenzyme A-d3 (ammonium salt) Exclusive - ≥99% deuterated product ✓ 2009-04-20 3.930939226519 3-hydroxy-3-methylglutaryl-coenzyme-a-d3-ammonium-salt HMG-CoA-d3 HMG-CoA mevalonic acid mevalonate cholesterol steroids sterols deuterateds deuterium standards GC MS LC mass spetrometry 3.930939226519
13006 3-methyl-2-Quinoxalinone 14003-34-0 ≥98% 2009-02-14 2.114559034171 3-methyl-2-quinoxalinone NSC 149824; NSC 17798; NSC 38589 BR Labs pyrimidines acids intermediates synthetic 2.114559034171
9000981 4-chloro-α-Cyanocinnamic Acid New 20374-46-3 ≥98% 2011-09-30 0E-12 4-chloro-cyanocinnamic-acid CI-CCA matrix-assisted laser desorption/ionization MALDI mass spectrometry MS matrix sensitivity peptides proteins analysis CICCA 0E-12
332101 4-hydroxy Nonenal-d3 - ≥99% deuterated product 2004-01-28 48.072991318074 4-hydroxy-nonenal-d3 4-HNE-d3 ROS alkenals aldehydes free radicals peroxidation lipid autoxidation reactive oxygen species 4-OH-nonenal 4-hydroxynonenal deuterium deuterateds 48.072991318074
9000876 4-hydroxy Nonenal Glutathione-d3 Exclusive - ≥99% deuterated product ✓ 2010-10-29 7.312685082873 4-hydroxy-nonenal-glutathione-d3 4-HNE-GSH-d3 oxidative stress lipids peroxidation 4-hydroxy nonenal 4-HNE deuterateds GSH-HNE internal standards mass spectrometry HNE-GSH-d3 deuteriums GC/MS LC/MS LC-MS MS 7.312685082873
10004174 4-oxo 2-Nonenal-d3 Exclusive - ≥99% deuterated product ✓ 2004-03-10 33.350589318600 4-oxo-2-nonenal-d3 4-ONE-d3 ROS Alkenals aldehydes free radicals peroxidation lipid autoxidation reactive oxygen species 4-OH-2-nonenal-d3 4-hydroxy2nonenald3 internal standards mass spectrometry GC/MS LC/MS gc-ms ic-ms deuterium deuterateds 33.350589318600
10007264 (±)5,6-DHET Lipid Maps MS Standard - ≥98% 2009-02-14 7.868591160221 -5-6-dhet-lipid-maps-ms-standard (±)5,6-DiHETrE epoxides epoxygenases DHT hydrolases (+/-)5,6-DiHETrEs MS mass spectrometry standards 7.868591160221
10009984 (±)5(6)-EET-d11 - ≥99% deuterated forms (d1-d11) 2007-06-06 12.800220994475 -5-6-eet-d11 (±)5(6)-EpETrE-d11 epoxides epoxygenases cytochrome P450 (+/-)5(6)-EpETrEs (+/-)5,6-EpETrEs 5,6-EETs fatty acids deuterated deuterium 12.800220994475
10007260 (±)5(6)-EET Lipid Maps MS Standard - >98% 2009-02-05 6.122527624309 -5-6-eet-lipid-maps-ms-standard (±)5(6)-EpETrE epoxides epoxygenases cytochrome P450 (+/-)5(6)-EpETrEs (+/-)5,6-EpETrEs 5,6-EETs fatty acids MS mass spectrometry standards 6.122527624309
13803 (±)5-epi CP 55,940 - ≥98% 2010-08-04 7.455193370166 -5-epi-cp-55-940 (±)-5-trans-CP 55,940 (±)-CP 55,940 cannabinoids analogs receptors pains analgesics by-products standards Δ9-THC delta-tetrahydrocannabidiol CP 55940 CP44950 CP-55940 CP55,940 7.455193370166
10006654 5-iPF2α-VI-d11 - ≥99% deuterated product 2005-03-17 98.054071823204 5-ipf2-vi-d11 isoprostanes peroxidation oxidative injury deuterateds deuteriums isotopes 8,12-isoprostanes iPF2alpha-VI-d11 prostaglandins iPF2a-VI-d11 urine peroxidative damage enantiomers stress 98.054071823204
334250 5-OxoETE-d7 - ≥99% deuterated product 22.323535911603 5-oxoete-d7 5-KETE-d7 GC/MS deuterium isotopes 5-KETEs oxo-acids 5oxoetes 5ketes 5-oxo-ete-d7 standards fatty LC/MS GC-MS LC-MS mass spectrometry deuterated 5-oxoETEs 22.323535911603
10007244 5-OxoETE Lipid Maps MS Standard 106154-18-1 >95% 2009-01-05 9.715497237569 5-oxoete-lipid-maps-ms-standard 5-KETE 5-HETEs oxo-acids 5-LOs metabolites chemotactic fatty 5-lipoxygenases 5-oxo-etes polyunsaturated PUFAs MS mass spectrometry standards 9.715497237569
10007255 5(S),15(S)-DiHETE Lipid Maps MS Standard 82200-87-1 ≥98% 2009-02-18 6.128360957643 5-s-15-s-dihete-lipid-maps-ms-standard 15-LOs dihydroxy fatty acids 15-lipoxygenases 5S,15S-DiHETEs 5,15-DiHETEs 5(S),15(S)-DiHETEs MS mass spectrometry standards 6.128360957643
10007252 5(S),6(R)-DiHETE Lipid Maps MS Standard 82948-88-7 >99% 2009-02-17 4.631786372007 5-s-6-r-dihete-lipid-maps-ms-standard LTA4 hydrolysis DHT 5S,6R-DiHETEs 5(S),6(R)-DiHETEs 5,6-DiHETEs MS mass spectrometry standards 4.631786372007
10007737 5(S),6(R)-Lipoxin A4-d5 Exclusive - ≥99% deuterated product ✓ 2009-04-09 45.540476519337 5-s-6-r-lipoxin-a4-d5 5(S),6(R)-LXA4-d5; 5(S),6(R),15(S)-TriHETE-d5 LXA4 lipoxins trihydroxy fatty acids leukocytes activation deuterated deuteriums MS LC mass spectrometry standards GC 45.540476519337
10007271 5(S),6(R)-Lipoxin A4 Lipid Maps MS Standard 89663-86-5 ≥95% 2009-02-18 43.257486187845 5-s-6-r-lipoxin-a4-lipid-maps-ms-standard 5(S),6(R),15(S)-TriHETE; 5(S),6(R)-LXA4 LXA4 lipoxins trihydroxy fatty acids leukocytes activation MS mass spectrometry standards 43.257486187845
10007253 5(S),6(S)-DiHETE Lipid Maps MS Standard 82948-87-6 ≥98% 2009-02-17 7.253057090239 5-s-6-s-dihete-lipid-maps-ms-standard LTA4 hydrolysis DHT 5S,6S-DiHETEs 5(S),6(S)-DiHETEs 5,6-DiHETEs MS mass spectrometry standards 7.253057090239
334230 5(S)-HETE-d8 330796-62-8 ≥99% deuterated product 35.300469613259 5-s-hete-d8 GC/MS deuterium isotopes 5-HETEs 5S-HETEs standards hydroxy fatty acids LC/MS GC-MS LC-MS mass spectrometry 5-HETE-d8 5S-HETE-d8 5(S)-HETEs deuterated 5(S)HETES 5(S)HETE-d8 35.300469613259
10007276 5(S)-HETE-d8 Lipid Maps MS Standard - ≥99% deuterated product 2009-02-26 24.627306629834 5-s-hete-d8-lipid-maps-ms-standard GC/MS deuterium isotopes 5-HETEs 5S-HETEs standards hydroxy fatty acids LC/MS GC-MS LC-MS mass spectrometry 5-HETE-d8 5S-HETE-d8 5(S)-HETEs deuterated 5(S)HETES 5(S)HETE-d8 24.627306629834
10007243 5(S)-HETE Lipid Maps MS Standard 70608-72-9 >98% 2009-01-06 24.919889502762 5-s-hete-lipid-maps-ms-standard arachidonic 5-lipoxygenases 5-LOs hydroxy acids 5S-HETEs 5-HETEs 5(S)-HETEs 5(S)HETEs fatty MS mass spectrometry standards 24.919889502762
10007257 5(S)-HpETE Lipid Maps MS Standard 71774-08-8 ≥98% 2009-02-04 8.932044198895 5-s-hpete-lipid-maps-ms-standard 5-LOs 5-HpETEs hydroperoxides 5S-HpETEs 5(S)HpETEs hydroperoxy 5-lipoxygenases 5(S)-HpETEs arachidonic fatty acids leukotrienes MS mass spectrometry standards 8.932044198895
10742 5(Z),8(Z),11(Z)-Eicosatrienoic Acid-d6 Exclusive - ≥99% deuterated product ✓ 2011-06-28 2.033020257827 5-z-8-z-11-z-eicosatrienoic-acid-d6 Mead Acid-d6 standards GC-MS GC/MS LC-MS LC/MS mass spectroscopy deuterium deuterateds fatty acids deficient PUFAs omega-3 omega-6 omega 6 omega 3 polyunsaturated ω-3 ω-6 ω3 ω6 ω 3 ω 6 2.033020257827
10007220 6,15-diketo-13,14-dihydro Prostaglandin F1α Lipid Maps MS Standard 63983-53-9 >98% 2008-12-13 33.361620626150 6-15-diketo-13-14-dihydro-prostaglandin-f1-lipid-maps-ms-standard 6,15-diketo-13,14-dihydro PGF1α MS Mass Spectrometry 6,15-diketo-13,14-dihydro-PGF1α 6,15-diketo-13,14-dihydro-PGF1alpha prostaglandins metabolites 33.361620626150
10007210 6-keto Prostaglandin E1 Lipid Maps MS Standard 67786-53-2 >99% 2008-11-03 50.241491712707 6-keto-prostaglandin-e1-lipid-maps-ms-standard 6-keto PGE1 6-keto-PGE1 metabolites prostaglandins GC LC MS mass spectrometry standards GC/MS LC/MS GC-MS LC-MS 50.241491712707
315210 6-keto Prostaglandin F1α-d4 - ≥99% deuterated product 16.896099447513 6-keto-prostaglandin-f1-d4 6-keto PGF1α-d4 GC/MS deuterium isotopes 6-keto-PGF1a-d4 6-keto-PGF1alpha-d4 6-keto-PGF1.alpha.-d4 internal standards prostaglandins PGFα deuterated LC/MS GC-MS LC-MS mass spectrometry d4 atherosclerosis 16.896099447513
10007274 6-keto Prostaglandin F1α-d4 Lipid Maps MS Standard - ≥99% deuterated product 2009-02-26 85.894254143646 6-keto-prostaglandin-f1-d4-lipid-maps-ms-standard 6-keto PGF1α-d4 GC/MS deuterium isotopes 6-keto-PGF1a-d4 6-keto-PGF1alpha-d4 6-keto-PGF1.alpha.-d4 internal standards prostaglandins PGFα deuterated LC/MS GC-MS LC-MS mass spectrometry d4 atherosclerosis 85.894254143646
10007219 6-keto Prostaglandin F1α Lipid Maps MS Standard 58962-34-8 >99% 2008-12-17 37.604464088398 6-keto-prostaglandin-f1-lipid-maps-ms-standard 6-keto PGF1α PGI2 metabolites prostaglandins 6-keto-PGF1alpha 6-keto-PGF1.alpha. atherosclerosis PGs MS mass spectrometry standards 37.604464088398
10007256 6-trans-12-epi Leukotriene B4 Lipid Maps MS Standard 71548-19-1 ≥97% 2009-01-28 40.597756906077 6-trans-12-epi-leukotriene-b4-lipid-maps-ms-standard 6-trans-12-epi LTB4; 5(S),12(S)-DiHETE leukotrienes 6-trans-12-epi-LTB4 isomers LTA4 hydrolysis LTs MS mass spectrometry standards 40.597756906077
10007254 6-trans Leukotriene B4 Lipid Maps MS Standard 71652-82-9 ≥97% 2009-02-17 54.599455406471 6-trans-leukotriene-b4-lipid-maps-ms-standard All trans LTB4; 6-trans LTB4; 5(S),12(R)-DiHETE leukotrienes 6-trans-LTB4 LTA4 hydrolysis MS mass spectrometry standards 54.599455406471
10010670 7-Aminoclonazepam-d4 - ≥99% deuterated product 2009-04-17 5.674033149171 7-aminoclonazepam-d4 seizures myotonic atonic epilepsy receptors acids deuterateds deuteriums standards GC/MS LC/MS GC-MS LC-MS mass spectrometry 5.674033149171
10006878 8,12-iso-iPF2α-VI-d11 Exclusive - ≥99% deuterated product ✓ 2005-09-01 7.075386740332 8-12-iso-ipf2-vi-d11 8,12-epi-iPF2α-VI-d11 GC/MS deuterium isotopes internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry analogs internal standards isoprostanes prostaglandins free-radical lipid peroxidation stero- regioisomers arachidonic acids 8-isoprostane 8-epi-PGF2.alpha. iPF2.alpha.-III oxidative stress Type VI class internal lactones facilitates extraction and purification neurochemistry neuroscience 7.075386740332
10009998 (±)8,9-DHET-d11 Exclusive - ≥99% deuterated forms (d1-d11) ✓ 2008-03-17 9.669005524862 -8-9-dhet-d11 (±)8,9-DiHETrE-d11 epoxides epoxygenases DHT hydrolases (+/-)14,15-DiHETrEs deuterated epoxide hydrolase deuterated deuterium 9.669005524862
10007265 (±)8,9-DHET Lipid Maps MS Standard - ≥98% 2009-02-11 7.775953038674 -8-9-dhet-lipid-maps-ms-standard (±)8,9-DiHETrE epoxides epoxygenases DHT hydrolases (+/-)8,9-DiHETrEs MS mass spectrometry standards 7.775953038674
10009532 (±)8(9)-EET-d11 - ≥99% deuterated forms (d1-d11) 2008-03-25 12.430920810313 -8-9-eet-d11 (±)8(9)-EpETrE-d11 epoxides epoxygenases cytochrome P450 (±)8,9-EpETrEs (+/-)8,9-EpETrEs fatty acids (+/-)8(9)EpETrEs 8(9)EETs eicosatrienoic 8,9-EETs deuterated racemic mixture 12.430920810313
10007261 (±)8(9)-EET Lipid Maps MS Standard - ≥98% 2009-02-10 7.550187845303 -8-9-eet-lipid-maps-ms-standard (±)8(9)-EpETrE epoxides epoxygenases cytochrome P450 (±)8,9-EpETrEs (+/-)8,9-EpETrEs fatty acids (+/-)8(9)EpETrEs 8(9)EETs eicosatrienoic 8,9-EETs MS mass spectrometry standards 7.550187845303
10011321 8-iso Prostaglandin E2-d4 Exclusive - ≥99% deuterated product ✓ 2008-08-14 4.518232044199 8-iso-prostaglandin-e2-d4 8-iso PGE2-d4; 8-epi PGE2-d4 8-isoprostanes 8-epi-PGE2 8-iso-PGE2 renal vasoconstriction prostaglandins deuteriums deuterateds 4.518232044199
10008935 8-iso Prostaglandin F1α-d9 - ≥99% deuterated product 2006-09-15 4.381767955801 8-iso-prostaglandin-f1-d9 8-epi PGF1α-d9 GC/MS deuteriums isotopes internal standards deuterated LC/MS GC-MS LC-MS mass spectrometry spectoscopy signalling 8-isoprostanes 8-epi-PGF1.alpha. 8-epi-PGF1alpha 8-iso-PGF1.alpha. 8-iso-PGF1alpha prostaglandins 4.381767955801
316350 8-iso Prostaglandin F2α-d4 211105-40-7 ≥99% deuterated product 50.421588397790 8-iso-prostaglandin-f2-d4 15-F2t-Isoprostane-d4; iPF2α-III-d4; 8-epi PGF2α-d4; 8-Isoprostane-d4 GC/MS deuterium isotopes 8-isoprostanes 8-epi-PGF2.alpha.-d4 8-epi-PGF2alpha-d4 8-iso-PGF2.alpha.-d4 8-iso-PGF2alpha-d4 internal standards prostaglandins mass spectrometry LC/MS GC-MS LC-MS deuterated 8-iso-PGF2a-d4 8-epi-PGF2a-d4 ipf2a neurochemistry 316351 50.421588397790
10007245 8(S)-HETE Lipid Maps MS Standard 98462-03-4 >98% 2009-01-05 6.517049723757 8-s-hete-lipid-maps-ms-standard hydroxy acids 8S-HETEs 8-HETEs fatty 8(S)-HETEs 8(S)HETEs MS mass spectrometry standards 6.517049723757
10009993 (±)9,10-DiHOME-d4 - ≥99% deuterated forms (d1-d4) 2007-06-01 4.717458563536 -9-10-dihome-d4 Leukotoxin diol-d4 epoxides epoxygenase leukotoxin cytochrome P450 (+/-)9(10)-DiHOMes (+/-)9,10-DiHOMes CYP450 deuterated duteriums 4.717458563536
10009995 (±)9(10)-EpOME-d4 - ≥99% deuterated forms (d1-d4) 2007-06-01 2.314217311234 -9-10-epome-d4 Leukotoxin-d4; 9,10-EODE-d4 epoxides epoxygenasse leukotoxin cytochrome P450 (+/-)9(10)-EpOMEs (+/-)9,10-EpOMEs epoxy fatty acids deuterated deuterium 2.314217311234
338420 9-OxoODE-d3 New - ≥99% deuterated product 2011-11-11 6.663195612138 9-oxoode-d3 9-KODE-d3 9-KODEs metabolites oxo-acids metabolites fatty 9-OxoODEs 9-oxo-ODEs deuterateds deuterium mass spectrometry LC-MS LC/MS reticulocyte mitochondrial plasma membranes lipids LC MS 15-LO OxoODEs 15-lipoxygenase linoleate residues acids oxo-fatty 6.663195612138
338410 9(S)-HODE-d4 - ≥99% deuterated product 17.761325966851 9-s-hode-d4 GC/MS deuterium isotopes 9-HODE-d4 standards 9S-HODE-d4 deuterated GC-MS LC/MS LC-MS 9-HODEs 9(S)-HODEs 9S-HODEs 9(S)HODES hydroxy fatty acids 9(S)HODE-d4 mass spectrometry 17.761325966851
10706 AM2201-d5 Exclusive - ≥99% deuterated product ✓ 2011-05-16 41.327683482825 am2201-d5 cannabinoids CB1 CB2 receptors pain forensic sciences CBs AM2201 AM-2201 deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry standards 41.327683482825
10010668 Amiodarone-d4 (hydrochloride) - ≥99% deuterated product 2009-06-25 0E-12 amiodarone-d4-hydrochloride deuterateds deuteriums standards GC/MS LC/MS GC-MS LC-MS mass spectrometry drugs inhibitors inhibits inhibition heart rate muscles 19774-82-4 0E-12
10010663 Amlodipine-d4 (besylate) - ≥99% deuterated product 2009-08-10 0E-12 amlodipine-d4-besylate deuterateds deuteriums standards GC/MS LC/MS GC-MS LC-MS mass spectrometry dihydropyridine pyridines calcium channel blocker angina pectoris hypertension 88150-42-9 0E-12
710000 AMP+ Mass Spectrometry Kit - 2010-09-13 1.447237569061 amp-mass-spectrometry-kit GELB Derivitization Kit 1.447237569061
390010 Arachidonic Acid-d8 69254-37-1 ≥99% deuterated product 207.601111878453 arachidonic-acid-d8 standards AA-d8 deuterium internal isotopes GC/MS GC-MS LC/MS LC-MS mass spectrometry deuterated fatty acids PUFAs polyunsaturated 207.601111878453
10007277 Arachidonic Acid-d8 Lipid Maps MS Standard 69254-37-1 ≥99% deuterated product 2009-03-02 76.100069060773 arachidonic-acid-d8-lipid-maps-ms-standard standards AA-d8 deuterium internal isotopes GC/MS GC-MS LC/MS LC-MS mass spectrometry deuterated fatty acids PUFAs polyunsaturated 76.100069060773
10007268 Arachidonic Acid Lipid Maps MS Standard 506-32-1 ≥98% 2009-07-06 16.677970534069 arachidonic-acid-lipid-maps-ms-standard fatty acids PUFAs polyunsaturated 5Z,8Z,11Z,14Z-eicosatetraenoic 5,8,11,14-eicosatetraenoic arachidonates essential MS mass spectrometry standards 16.677970534069
390014 Arachidonic Acid methyl ester-d8 Exclusive - ≥99% deuterated product ✓ 2010-02-12 14.038044198895 arachidonic-acid-methyl-ester-d8 Methyl Arachidonate-d8 PUFA FAME polyunsaturated fatty acids esters GC exogenous 5Z,8Z,11Z,14Z-eicosatetraenoic 5,8,11,14-eicosatetraenoic diets dietary arachidonates essential deuterateds deuteriums standards LC/MS MS mass spectrometry GC/MS LC-MS GC-MS 14.038044198895
10011178 Arachidonoyl Ethanolamide-d4 946524-40-9 ≥99% deuterated product 2008-03-04 35.926298342541 arachidonoyl-ethanolamide-d4 AEA-d4; Anandamide-d4 deuterium GC/MS internal isotopes standards ethanolamides LC/MS mass spectrometry cannabinoids fatty acids deuterated neurochemistry neuroscience ethanolamines cannabinoids cbs synthetic 35.926298342541
390050 Arachidonoyl Ethanolamide-d8 - ≥99% deuterated product 35.021906077348 arachidonoyl-ethanolamide-d8 Anandamide-d8; AEA-d8 deuterium GC/MS internal isotopes standards ethanolamides GC-MS LC/MS LC-MS mass spectrometry cannabinoids deuterated fatty acids neurochemistry neuroscience ethanolamines endocrinology 35.021906077348
10007270 Arachidonoyl Ethanolamide Lipid Maps MS Standard 94421-68-8 ≥98% 2009-02-18 6.314611134721 arachidonoyl-ethanolamide-lipid-maps-ms-standard AEA; Anandamide cannabinoids neurotransmitter ligands lipids CB1 CB2 receptors AEA fatty acids neuroscience neurochemistry ethanolamines ethanolamides endocrinology MS mass spectrometry standards 6.314611134721
10007531 Arachidonoyl Glycine-d8 - ≥99% deuterated product 2005-09-13 17.672720994475 arachidonoyl-glycine-d8 N-Arachidonyl Glycine-d8; NAGly-d8 deuterium GC/MS internal isotopes standards GC-MS LC/MS LC-MS mass spectrometry deuterated cannabinoids ligands lipids CB1 receptors AEA anandamides ethanolamides fatty acids neurochemistry neuroscience 17.672720994475
10007213 Bicyclo Prostaglandin E2 Lipid Maps MS Standard 7415-09-1 >98% 2008-11-05 4.765386740331 bicyclo-prostaglandin-e2-lipid-maps-ms-standard Bicyclo PGE2 bicyclo-PGE2 metabolites prostaglandins bicyclo GC LC MS mass spectrometry standards GC/MS LC/MS GC-MS LC-MS 4.765386740331
9000528 Bromoenol lactone-d7 - ≥99% deuterated product 2010-06-21 8.378650355169 bromoenol-lactone-d7 Haloenol lactone-d7; HELSS-d7; BEL-d7 selective iPLA2 inhibitors phospholipases PLAs deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS inhibited inhibition 8.378650355169
10010681 Capecitabine-d11 - ≥99% deuterated compound 2009-03-04 5.745856353591 capecitabine-d11 154361-50-9 5-DFCR 5'-DFCR 5-DFUR 5'-DFUR 5'-deoxy-5-fluorocytidine 5'-deoxy-5-fluororidine SPI BIO 154361-50-9 5.745856353591
10010685 Capecitabine-d8 - ≥99% deuterated compound 2009-03-04 11.491712707182 capecitabine-d8 154361-50-9 5-DFCR 5'-DFCR 5-DFUR 5'-DFUR 5'-deoxy-5-fluorocytidine 5'-deoxy-5-fluororidine SPI BIO 154361-50-9 11.491712707182
10009523 CAY10429-d3 - ≥99% deuterated product 2007-10-02 1.414364640884 cay10429-d3 Abnormal Cannabidiol-d3; Abn-CBD-d3 endocannabinoids cannabidiols abnormal abn-cbd non-CB1 non-CB2 receptors agonists BV-2 microglials hypotensives GPCR neurochemistry neurosciences cannabindoids CB1 CB2 deuterated deuterium mass spectrometry LC-MS GC-MS AbnCBD LC/MS GC/MS cannabinoids cbs synthetic 1.414364640884
9000595 CEP-Lysine-d4 Exclusive - ≥99% deuterated product ✓ 2010-08-23 19.966132596685 cep-lysine-d4 Docosahexaenoic acid DHA oxidative stress 2-(ω-carboxyethyl)pyrrole CEP carboxyethylpyrrole advanced glycation end products biomarkers age-related macular degeneration deuterateds internal standard GC LC chromatography mass spectrometry GC-MS LC-MS GC/MS LC/MS deuterium 19.966132596685
10686 (±)-CP 47,497-C8-homolog-d7 (solution) Exclusive - ≥99% deuterated forms (d1-d7) ✓ 2011-03-14 21.771818898971 -cp-47-497-c8-homolog-d7-solution Cannabicyclohexanol-d7 cannabinoids analgesia analgesic CB1 hypothermia motor supressants anticonvulsant Δ9-THC C8 analog CP 47,497-C8 CP4 ,497-C8 cannabinoids cbs synthetic deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS GC LC standards stds 10914 21.771818898971
10687 (±)-CP 47,497-d11 (solution) Exclusive - ≥99% deuterated forms (d1-d11) ✓ 2011-02-16 23.337757971923 -cp-47-497-d11-solution receptors agonist CB1 potent cannabinoid DELTA9-THC Δ9-THC CP47,497 CP-47,497 CP47497 CP-47497 cannabinoids cbs synthetic deuterated deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS 10907 23.337757971923
10249 Deoxy-5-fluorocytidine-D2 New 66335-38-4 ≥99% deuterated compound 2012-01-19 0E-12 deoxy-5-fluorocytidine-d2 5-DFCR-D2 SPI BIO deuterateds deuterium chemotherapy breasts colon cancers prodrugs 5-fluorouracil tumors DNA growth tissues enzymes metabolites 5'-deoxy-5-fluorocytidine 5'-deoxy-5-fluorouridine 5'-DFCR 5'-DFUR 1226642-70-1 0E-12
10007901 D-erythro-Sphingosine C-15 86555-28-4 ≥98% 2010-08-20 7.077147162230 d-erythro-sphingosine-c-15 sphingosines internal standard 10007907 unsaturated hydrocarbon chain 18-carbon 18 carbons dihydrosphingosine mammalian tissues 7.077147162230
10007902 D-erythro-Sphingosine C-17 6918-48-5 ≥98% 2010-08-20 7.581416373681 d-erythro-sphingosine-c-17 sphingosines kinases internal standard C17 C 17 human skin sphingoid chromatographic spectrometric dihydrosphingosine 10007907 7.581416373681
10458 Dihomo-γ-Linolenic Acid-d6 Exclusive - ≥99% deuterated product ✓ 2011-06-13 10.538974831184 dihomo-linolenic-acid-d6 DGLA-d6 deuterated LC/MS GC-MS LC-MS mass spectrometry polyunsaturated dihomo-g-linolenic dihomo-γ-linolenic dihomo-gamma-linolenic omega-6 ω-6 fatty acids antagonists arachidonic receptors LTB4 deuterium 10.538974831184
10696 dinor-12-oxo Phytodienoic Acid-d5 Exclusive - ≥99% deuterated product ✓ 2011-04-04 5.605423572743 dinor-12-oxo-phytodienoic-acid-d5 dinor-12-oxo PDA-d5; dinor-OPDA-d5 jasmonates pathways plants hormones senescence development intermediates jasmonic acids glycerolipids galactolipids arabidopsides dnOPDA dn-OPDA deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS LC GC standards 5.605423572743
11218 DMABA-d6 NHS ester New 1175002-04-6 ≥99% deuterated form (d1-d6) 2012-02-07 121.851851851852 dmaba-d6-nhs-ester 4-(dimethylamino) Benzoic Acid-d6; DMABA N-hydroxysuccinimide ester-d6; N-Succinimidyl 4-(dimethylamino)benzoate-d6 GC/MS deuterium deuterateds internal standards LC/MS GC-MS LC-MS mass spectrometry MS phosphatidylethanolamines FAAH fatty acids synthesis PUFA polyunsaturated fatty acyl phospholipids probes electorspray tandem PE lipids markers 121.851851851852
10005057 Docosahexaenoic Acid-d5 - ≥99% deuterated product 2005-03-16 202.916675874770 docosahexaenoic-acid-d5 DHA-d5; Cervonic Acid-d5 standards deuterium internal isotopes GC/MS GC-MS LC/MS LC-MS mass spectrometry deuterated polyunsaturated fatty acids PUFAs omega-3 brain .omega.-3 w-3 retinol neuronal membranes neonatal deprivation hypertension 202.916675874770
10006829 Docosahexaenoic Acid Quant-PAK - 2005-08-08 45.867513812154 docosahexaenoic-acid-quant-pak DHA Quant-PAK; Cervonic Acid Quant-PAK Quant-PAKs polyunsaturated fatty acids PUFAs omega-3 brain .omega.-3 w-3 standards deuterium internal isotopes GC/MS GC-MS LC/MS LC-MS mass spectrometry deuterated retinol neuronal membranes neonatal deprivation hypertension neurochemistry packs 45.867513812154
10010671 Donepezil-d7 - ≥99% deuterated product 2009-04-15 0E-12 donepezil-d7 acetyl cholinesterase inhibitors inhibits inhibition alzheimers disease cortical 120014-06-4 deuterateds deuteriums standards GC/MS LC/MS GC-MS LC-MS mass spectrometry 0E-12
10253 Doxifluridine New 3094-09-5 ≥95% 2012-01-19 0E-12 doxifluridine 5-DFUR 1226642-64-3 5-fluoro-5'-deoxyuridine 5-fluorodesoxyuridine 5-dFUrd flutron furtulon Ro 21-9738 Ro-21-9738 0E-12
10010675 Doxifluridine-d2 84258-25-3 ≥99% deuterated compound 2009-08-05 3.909392265193 doxifluridine-d2 5-DFUR-d2 SPI BIO deuterated 5DFUR 5 DFUR mass spectrometry 5-DFCR 5-DFUR 5,-deoxy-5-fluorocytidine 5'-DFCR 5'-DFUR 5'-deoxy-5-fluororidine prodrug 5-fluororacil 154361-50-9 3.909392265193
10005056 Eicosapentaenoic Acid-d5 145191-14-6 ≥99% deuterated product 2005-08-30 232.708402836386 eicosapentaenoic-acid-d5 EPA-d5; Timnodonic Acid-d5 GC/MS deuteriums isotopes internal standards deuterateds LC/MS GC-MS LC-MS mass spectrometry fatty acids PUFAs omega-3 .omega.-3 polyunsaturated w-3 inflammation analogs marine organisms coronary heart diseases thrombosis ischemic brain injury scaly dermatitis inflammatory 232.708402836386
10011721 ent-8-iso Prostaglandin F2α-d9 Exclusive - ≥99% deuterated product ✓ 2008-08-11 9.991418047881 ent-8-iso-prostaglandin-f2-d9 ent-8-epi PGF2α-d9; ent-15-F2t-Isoprostane-d9; ent-8-iso PGF2α-d9 deuterated deuterium inhibitors inhibits inhibition 8-iso-PGF2.alpha. vasoconstriction platelet aggregation oxidative stress isoprostanes 15-F2t-isoprostane GC/MS GC-MS LC/MS LC-MS mass spectrometry 9.991418047881
10919 (±)-epi CP 47, 497 - ≥98% 2011-05-05 13.604473642789 -epi-cp-47-497 3-trans CP 47,497 (±)-trans-CP 47,497 cannabinoids analogs receptors CB1 standards (±)-CP47,497 analgesic potency epimer THC .delta.-THC (±)-iso Δ-tetrahydrocannabidiol CP 47497 CP47497 CP-47497 CP-47,497 cbs synthetic 13801 13.604473642789
13801 (±)-epi CP 47,497 (solution) Exclusive - ≥98% ✓ 2010-08-04 11.620194114805 -epi-cp-47-497-solution 3-trans CP 47,497 (±)-trans-CP 47,497 cannabinoids analogs receptors CB1 standards (±)-CP47,497 analgesic potency epimer THC .delta.-THC (±)-iso Δ-tetrahydrocannabidiol CP 47497 CP47497 CP-47497 CP-47,497 cbs synthetic 10919 11.620194114805
10010654 Felodipine-d3 - ≥99% deuterated product 2009-04-17 0E-12 felodipine-d3 pharmaceutical reference standard blood pressure smooth muscle deuterateds deuteriums standards GC/MS LC/MS GC-MS LC-MS mass spectrometry 0E-12
316767 Fluprostenol-d4 - ≥99% deuterated product 1.723756906078 fluprostenol-d4 16-m-trifluoromethylphenoxy tetranor Prostaglandin F2α-d4 GC/MS deuterium isotopes internal standards GC-MS LC/MS LC-MS mass spectrometry (+)-fluprostenol prostaglandins deuterated 1.723756906078
9000497 GW 9662-d5 Exclusive - ≥99% deuterated product ✓ 2009-09-30 44.903296500920 gw-9662-d5 deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry GW-9662 GW9662 ligands ppar.gamma. γ ppargamma peroxisome proliferator-activated nuclear endocrinology receptors antagonists atherosclerosis TZDs thiaolidinediones PPARs 44.903296500920
10570 Heneicosapentaenoic Acid-d6 - >99% deuterated product 2010-12-13 19.345914756166 heneicosapentaenoic-acid-d6 24257-10-1 c21:5 C-21:5 C 21:5 omega-3 .omega.-3 w-3 deterateds deuteriums standards mass spectrometry LC/MS GC/MS LC-MS GC-MS MS 19.345914756166
10010676 Hydrochlorothiazide-d2 15N2 - ≥99% deuterated product 2009-05-02 0E-12 hydrochlorothiazide-d2-15n2 58-93-5 8049-49-8 125727-50-6 edema hypertension diabetes deuterated deuterium 0E-12
10010674 Hydroxyalprazolam-d5 136765-24-7 ≥99% deuterated product 2009-06-30 0E-12 hydroxyalprazolam-d5 deuterateds deuteriums standards GC/MS LC/MS GC-MS LC-MS mass spectrometry triazolobenzodiazepine anti-anxiet antianxiety sedative hypnotic panic disorders 0E-12
10010669 Hydroxy Bupropion-d9 - ≥99% deuterated product 2009-04-17 11.113259668508 hydroxy-bupropion-d9 aminoketone ketones antideppressant dopamine smoking cessation treatment deuterateds deuteriums standards GC/MS LC/MS GC-MS LC-MS mass spectrometry 11.113259668508
316300 iPF2α-VI-d4 214977-79-4 ≥99% deuterated product 25.528738489871 ipf2-vi-d4 8-iso-5(R),6E,14Z-Prostaglandin F2α-d4 deuteriums isotopes 8-isoprostanes iPF2.alpha.-VI-d4 iPF2alpha-VI-d4 lipid peroxidation oxidative ipf2a injury stress prostaglandins deuterated iPF2a-VI-d4 pgf2a deuterium GC/MS GC-MS LC/MS LC-MS mass specrometry 25.528738489871
10486 JWH 007-d9 - ≥99% deuterated product 2010-10-11 42.265883416430 jwh-007-d9 agonists cannabinoids receptors CB1 CB2 Δ9-THC pain antinociception hypothermia catalepsy deuterateds deuteriums mass spectrometry MS standards JWHs JWH007-d9 JWH-007-d9 cannabinoids cbs synthetic JWH7-d9 JWH 7-d9 JWH-7-d9 42.265883416430
10660 JWH 015-d7 Exclusive - ≥99% deuterated product ✓ 2011-02-21 49.700773480663 jwh-015-d7 agonists CB1 CB2 cannabinoids aminoalkylindole receptors MS multiple sclerosis WIN 55212-2 ACEA CD4+ T cells IFN-γ IFN-gamma CD40 JAK STAT1 endocrinology neurochemistry JWH015 JWH-015 cannabinoids cbs synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry deuteriums deuterateds standards JWH15-d7 JWH 15-d7 JWH-15-d7 49.700773480663
10711 JWH 018 2-hydroxyindole metabolite-d9 Exclusive - ≥99% deuterated product ✓ 2011-02-25 24.113084443524 jwh-018-2-hydroxyindole-metabolite-d9 cannabinoids CB1 CB2 agonists selective receptors WIN 55,212-2 JWH-018 JWH018 deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS synthetic cannabimimetics urine urinary metabolites glucuroconjugate forensics CBs monohydroxylated standards JWH-018 JWH018 JWH18 JWH-18 JWH 18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 24.113084443524
10712 JWH 018 4-hydroxyindole metabolite-d9 Exclusive - ≥99% deuterated product ✓ 2011-02-25 33.195926243109 jwh-018-4-hydroxyindole-metabolite-d9 cannabinoids CB1 CB2 agonists selective receptors WIN 55,212-2 JWH-018 JWH018 deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS synthetic cannabimimetics urine urinary metabolites 1 glucuroconjugate forensics smoking mixtures spices standards JWH-018 JWH018 JWH18 JWH-18 JWH 18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 33.195926243109
10713 JWH 018 5-hydroxyindole metabolite-d9 Exclusive - ≥99% deuterated product ✓ 2011-03-11 27.502696454894 jwh-018-5-hydroxyindole-metabolite-d9 cannabinoids CB1 CB2 agonists selective receptors WIN 55,212-2 JWH-018 JWH018 deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS synthetic cannabimimetics urine urinary metabolites 1 glucuroconjugate forensics smoking mixtures spices standards M-2 M2 JWH-018 JWH018 JWH18 JWH-18 JWH 18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 27.502696454894
10714 JWH 018 6-hydroxyindole metabolite-d9 Exclusive - ≥99% deuterated product ✓ 2011-03-25 47.737945073679 jwh-018-6-hydroxyindole-metabolite-d9 cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugates forensics JWH-018 JWH018 209414-07-3 science pain neuroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite three 3 M-3 M3 CBs smoking mixture spices cbs synthetic deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS standards JWH-018 JWH018 JWH18 JWH-18 JWH 18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 47.737945073679
10715 JWH 018 7-hydroxyindole metabolite-d9 Exclusive - ≥99% deuterated product ✓ 2011-07-26 29.253143271526 jwh-018-7-hydroxyindole-metabolite-d9 WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugates forensics JWH-018 JWH018 209414-07-3 science pain neuroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite three 3 M-3 M3 smoking mixture spices synthetic deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS standards cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 CBs cannabimimetics urine urinary metabolites glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic sciences pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite 4 M4 M-4 smoking mixtures spices synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 29.253143271526
13824 JWH 018-d9 (solution) - ≥99% deuterated product 2010-06-21 54.097431772776 jwh-018-d9-solution cannabinoids CB1 CB2 agonists selective receptors WIN 55,212-2 JWH-018 JWH018 deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS cbs synthetic JWH018-d9 JWH-018-d9 JWH-18-d9 JWH 18-d9 JWH18-d9 JWH18d9 10901 54.097431772776
10926 (±)-JWH 018 N-(4-hydroxypentyl) metabolite-d5 Exclusive - ≥99% deuterated forms (d1-d5) ✓ 2011-06-28 51.336977083511 -jwh-018-n-4-hydroxypentyl-metabolite-d5 JWH-018 JWH018 JWH18 JWH-18 JWH18 cannabinoids WIN 55,212-2 urinary metabolites forensics CBs WIN 55212-2 WIN55,212-2 WIN55212-2 monohydroxylation metabolism N-alkyl chains agonists peripheral central receptors smoking mixtures GC/MS deuteriums standards deuterateds LC/MS GC-MS LC-MS mass spectrometry 51.336977083511
10933 JWH 018 N-(5-hydroxypentyl) metabolite-d5 Exclusive - ≥99% deuterated product ✓ 2011-06-22 79.757840793639 jwh-018-n-5-hydroxypentyl-metabolite-d5 cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic science pain neuroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite two 2 smoking mixtures spices CBs M-5 M5 synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 bath salts LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums agonists selective M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 79.757840793639
9000867 JWH 018 N-pentanoic acid metabolite-d4 Exclusive - ≥99% deuterated product ✓ 2010-09-15 280.977045593935 jwh-018-n-pentanoic-acid-metabolite-d4 JWH-018 JWH018 deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 JWH-018 JWH018 JWH18 JWH-18 JWH18 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite 6 six CBs M6 M-6 smoking mixtures spices synthetic M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 280.977045593935
10716 JWH 073 2-hydroxyindole metabolite-d7 Exclusive - ≥99% deuterated product ✓ 2011-03-10 19.228790996521 jwh-073-2-hydroxyindole-metabolite-d7 cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites monohydroxylated forensics JWH 073 JWH-073 JWH073 JWH73 JWH-73 JWH73 glucuroconjugate JWH-073 JWH073 CBs smoking mixtures spices synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums standards CBs M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 19.228790996521
10717 JWH 073 4-hydroxyindole metabolite-d7 Exclusive - ≥99% deuterated product ✓ 2011-02-21 19.579435563740 jwh-073-4-hydroxyindole-metabolite-d7 cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics JWH 073 Metabolite 1 JWH-073 JWH073 M-1 CBs smoking mixtures spices synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums standards CBs JWH 073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 19.579435563740
10718 JWH 073 5-hydroxyindole metabolite-d7 Exclusive - ≥99% deuterated product ✓ 2011-03-11 21.566729128299 jwh-073-5-hydroxyindole-metabolite-d7 cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics Metabolite 2 JWH-073 JWH073 M-2 CBs smoking mixtures spices synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums standards CBs JWH 073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 21.566729128299
10719 JWH 073 6-hydroxyindole metabolite-d7 Exclusive - ≥99% deuterated product ✓ 2011-03-11 19.228790996521 jwh-073-6-hydroxyindole-metabolite-d7 cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics JWH 073 Metabolite 3 JWH-073 JWH073 M-3 CBs smoking mixtures spices synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums standards CBs JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 19.228790996521
10720 JWH 073 7-hydroxyindole metabolite-d7 Exclusive - ≥99% deuterated product ✓ 2011-07-25 25.409004024282 jwh-073-7-hydroxyindole-metabolite-d7 cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics CBs deuterateds deuterium mass spectrometry MS LC/MS LC-MS GC-MS GC/MS WIN55212-2 WIN552122 pain neuroscience JWH 073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 25.409004024282
9000868 JWH 073-d7 (solution) Exclusive - ≥99% deuterated product ✓ 2010-08-10 35.952230308723 jwh-073-d7-solution deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS standards JWH-073 JWHs JWH073 JWH73 JWH-73 JWH 73 cannabinoids CB1 receptors CB2 peripheral central cbs synthetic JWH073d7 JWH-073-d7 JWH073-d7 JWH73-d7 JWH-73-d7 JWH73-d7 JWH73d7 10905 35.952230308723
10934 JWH 073 N-(4-hydroxybutyl) metabolite-d5 Exclusive New - ≥99% deuterated product ✓ 2011-10-14 66.724011217090 jwh-073-n-4-hydroxybutyl-metabolite-d5 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M deuterated deuterium metabolites cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics JWH 073 Metabolite 5 JWH-073 smoking JWH073 CBs mixtures spices 66.724011217090
10511 JWH 081-d9 New - ≥99% deuterated product 2011-09-08 66.443078325278 jwh-081-d9 cannabinoids receptors WIN 55212-2 CB1 CB2 cannabimimetics urine forensics endocannabinoids indoles central peripheral receptors cannabinoids CBs synthetic JWH-081 JWH 81 JWH-81 JWH81 standards deuterated deuterium mass spectrometry LC-MS LC/MS GC-MS GC/MS MS 66.443078325278
10512 JWH 122-d9 New - ≥99% deuterated product 2011-09-08 41.408151914141 jwh-122-d9 JWHs JWH-122 JWH122 cannabinoids CB1 CB2 CBs CB-1 CB-2 receptors potent synthetic forensics pain central peripheral cannabinoids CBs synthetic standards deuterated deuterium mass spectrometry LC-MS LC/MS GC-MS GC/MS MS 41.408151914141
10903 JWH 200-d5 - ≥99% deuterated product 2011-05-06 10.563329852221 jwh-200-d5 cannabinoids receptors agonists CB1 pain antinociception deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS cannabinoids cbs synthetic JWH-200-d5 JWH200-d5 10903 10.563329852221
10682 JWH 200-d5 (solution) - ≥99% deuterated product 2011-01-07 33.996941087390 jwh-200-d5-solution cannabinoids receptors agonists CB1 pain antinociception deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS cannabinoids cbs synthetic JWH-200-d5 JWH200-d5 10903 33.996941087390
10510 JWH 210-d9 New - ≥99% deuterated product 2011-09-08 48.455738971633 jwh-210-d9 cannabimimetic cannabinoids alklyindoles CB1 CB2 receptors agonists CBs JWH-210 JWH210 JWHs standards deuterated deuterium mass spectrometry LC-MS LC/MS GC-MS GC/MS MS pain 48.455738971633
10661 JWH 250-d5 Exclusive - ≥99% deuterated product ✓ 2011-02-14 32.813926949452 jwh-250-d5 cannabinoids receptors agonists CB1 pain antinociception deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS cannabinoids cbs synthetic JWH-250-d5 JWH250-d5 32.813926949452
10514 JWH 398-d9 Exclusive New - ≥99% deuterated product ✓ 2011-08-25 50.086297295345 jwh-398-d9 JWH398 JWH-398 standards cannabinoids CBs JWHs forensics sciences deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS 50.086297295345
10006556 Latanoprost-d4 - ≥99% deuterated product 2005-11-30 21.322550644567 latanoprost-d4 17-phenyl-13,14-dihydro trinor Prostaglandin F2α-d4 isopropyl ester eyes glaucoma prostaglandins agonists FP receptors ophthalmology ophthalmological intraocular acids GC/MS deuterium isotopes internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry 17-phenyl-13,14-dihydro-trinor-PGF2.alpha.-d4 17-phenyl-13,14-dihydro-trinor-PGF2alpha-d5 17-phenyl-13,14-dihydro trinor-PGF2a-d4 PGs 21.322550644567
316822 Latanoprost ethyl amide-d4 - ≥99% deuterated product 2006-03-16 29.224337016574 latanoprost-ethyl-amide-d4 Lat-NEt-d4 eyes glaucoma prostaglandins agonists FP receptors ophthalmology ophthalmological intraocular acids GC/MS deuterium isotopes internal standards deuterated LC/MS GC-MS LC-MS mass spectrometry 29.224337016574
316811 Latanoprost (free acid)-d4 - ≥99% deuterated product 38.763618784530 latanoprost-free-acid-d4 PhXA 85-d4; 17-phenyl-13,14-dihydro trinor Prostaglandin F2α-d4; Lat-FA-d4 eyes glaucoma prostaglandins agonists FP receptors ophthalmology ophthalmological intraocular acids GC/MS deuterium isotopes internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry 17-phenyl-13,14-dihydro-trinor-PGF2.alpha.-d4 PhXA85-d4 17-phenyl-13,14-dihydro-trinor-PGF2alpha-d5 LatFA-d4 17-phenyl-13,14-dihydro trinor-PGF2a-d4 38.763618784530
320110 Leukotriene B4-d4 - ≥99% deuterated product 133.897044198895 leukotriene-b4-d4 LTB4-d4 GC/MS LTB4-d4 deuterium internal standards isotopes leukotrienes GC-MS mass spectrometry LC/MS LC-MS deuterated spectroscopy atherosclerosis mass spectrometry 133.897044198895
10007240 Leukotriene B4 Lipid Maps MS Standard 71160-24-2 ≥97% 2009-01-14 32.633635359115 leukotriene-b4-lipid-maps-ms-standard LTB4 leukotrienes LTB4 inflammation chemotaxis atherosclerosis LTs MS mass spectrometry standards 32.633635359115
10006198 Leukotriene C4-d5 - ≥99% deuterated product 2007-04-11 98.847513812155 leukotriene-c4-d5 LTC4-d5 cysteinyl-leukotrienes LTC4 asthma SRS-A slow-reacting substance anaphylaxis allergy peptido-leukotrienes cysteinyl-LTs peptido-LTs cys-LTs GC/MS deuterium isotopes LTC4-d5 internal standards deuterated LC/MS GC-MS LC-MS mass spectrometry 98.847513812155
10007241 Leukotriene C4 Lipid Maps MS Standard 72025-60-6 >97% 2009-01-07 32.956408839779 leukotriene-c4-lipid-maps-ms-standard LTC4 cysteinyl-leukotrienes LTC4 asthma SRS-A slow-reacting substance anaphylaxis allergy peptido-leukotrienes cysteinyl-LTs peptido-LTs cys-LTs MS mass spectrometry standards asthma cyslts 32.956408839779
10006199 Leukotriene D4-d5 - ≥99% deuterated product 2008-04-23 37.383133385950 leukotriene-d4-d5 LTD4-d5 peptido-leukotrienes LTD4 asthma urine uninary allergy SRS-A slow-reacting substance anaphylaxis cysteinyl-LTs peptido-LTs cys-LTs cysteinyl-leukotrienes deuterated deuterium cysLTs GC/MS GC-MS LC/MS LC-MS mass spectrometry 37.383133385950
10007858 Leukotriene E4-d5 - ≥99% deuterated product 2008-04-08 82.929539594843 leukotriene-e4-d5 LTE4-D5 peptido-leukotrienes LTE4 asthma urine uninary allergy SRS-A slow-reacting substance anaphylaxis cysteinyl-LTs peptido-LTs cys-LTs cysteinyl-leukotrienes deuterated deuterium cysLTs GC/MS GC-MS LC/MS LC-MS mass spectrometry 82.929539594843
10007242 Leukotriene E4 Lipid Maps MS Standard 75715-89-8 >97% 2009-01-06 44.596748224151 leukotriene-e4-lipid-maps-ms-standard LTE4 peptido-leukotrienes LTE4 asthma urine uninary allergy SRS-A slow-reacting substance anaphylaxis cysteinyl-LTs peptido-LTs cys-LTs cysteinyl-leukotrienes LTs MS mass spectrometry standards 44.596748224151
390150 Linoleic Acid-d4 Exclusive 79050-23-0 ≥99% deuterated product ✓ 17.203977900552 linoleic-acid-d4 standards deuterated deuterium GC/MS internal isotopes GC-MS LC/MS LC-MS mass spectrometry fatty acids 17.203977900552
9000553 Linoleoyl Ethanolamide-d4 Exclusive - ≥99% deuterated product ✓ 2010-01-13 7.936983425414 linoleoyl-ethanolamide-d4 cannabinoids neurotransmitter ethanolamides fatty acids neurochemistry neuroscience ethanolamines linoleyl deuterateds deuteriums LC-MS GC/MS GC-MS mass spectrometry standards LC/MS MS cbs synthetic 7.936983425414
360906 Lyso-PAF C-16-d4 - ≥99% deuterated product 25.751270718232 lyso-paf-c-16-d4 Lyso-Platelet-activating Factor C-16-d4 PAFs deuterium GC/MS internal isotopes deuterated lyso-PAF-C-16-d4 standards GC-MS LC/MS LC-MS mass spectrometry platelet-activating factors 25.751270718232
10010228 Lyso-PAF C-18 -d4 Exclusive - ≥99% deuterated product ✓ 2010-11-03 10.797270718231 lyso-paf-c-18-d4 PAFs platelet-activating factors deuterateds deuterium mass spectrometry MS LC/MS GC/MS LC-MS GC-MS 10.797270718231
10679 Methylenedioxy Pyrovalerone-d8 (hydrochloride) 1246820-09-6 ≥99% deuterated product 2011-02-15 37.891464123511 methylenedioxy-pyrovalerone-d8-hydrochloride MDPV-d8 3,4-methylenedioxypyrovalerone inhibitors neurotransmitters dopamine norepinephrine MDMA ecstasy neuroscience forensics designer drugs deuterateds deuteriums GC/MS GC-MS LC/MS LC-MS mass spectrometry MS standards 37.891464123511
10010660 Mifepristone-d3 - ≥99% deuterated compound 2009-03-04 0E-12 mifepristone-d3 84371-65-3 SPI BIO normal deuterated progestional glucocorticoid hormone agonist hypercortisolism cushing syndrome 0E-12
10010333 Misoprostol (free acid)-d5 - ≥99% deuterated product 2008-01-16 20.789350828729 misoprostol-free-acid-d5 PGE1 analogs agonists EP2 EP3 EP4 cytotec cytoprotection SC-29333 SC29333 receptors RU486 RU-486 deuterated deuteriums GC/MS GC-MS LC/MS LC-MS mass spectrometry 20.789350828729
10007899 N-butyryl-L-Homoserine lactone-d5 - ≥99% deuterated product 2006-05-05 9.536896032145 n-butyryl-l-homoserine-lactone-d5 C4-HSL-d5 GC/MS deuteriums isotopes internal standards deuterateds LC/MS GC-MS LC-MS mass spectrometry bacterial quorums sensing signaling molecules regulatory regulates systems genes expressions cells density infections transcriptional regulators LuxIR proteins synthesis N-acylhomoserine lactones AHL cellular metabolism regulation virulence slime biofilms transduction activation signalling 9.536896032145
10007897 N-hexanoyl-L-Homoserine lactone-d3 - ≥99% deuterated product 2006-05-05 9.331580110497 n-hexanoyl-l-homoserine-lactone-d3 C6-HSL-d3 GC/MS deuteriums isotopes internal standards deuterated LC/MS GC-MS LC-MS mass spectrometry spectoscopy bacterial quorums sensing signaling molecules regulatory regulates systems genes expressions cells density infections transcriptional regulators LuxIR proteins synthesis N-acylhomoserine lactones AHL cellular metabolism regulation virulence cystic fibrosis slime biofilms agriculture aquaculture food spoilage septicemia fish activation transduction signalling 9.331580110497
10010653 Nisoldipine-d3 - ≥99% deuterated product 2009-04-15 0E-12 nisoldipine-d3 63675-72-9 86189-67-5 calcium channel dihydropyridine cardiac failure angina deuterateds deuteriums standards GC/MS LC/MS GC-MS LC-MS mass spectrometry 0E-12
9000432 Oleic Acid-d17 - ≥99% deuterated product 2010-08-30 5.419668508287 oleic-acid-d17 deuterium internal isotopes GC/MS GC-MS LC/MS LC-MS mass spectrometry deuterated fatty acids monounsaturated 9Z-octadecenoic Acid cis-9-Octadecenoic Oleic Acids 12-hydroxy Oleic Acids, 12 hydroxy cis-9-Octadecenoic Acid cis 9 Octadecenoic Acid Acids, 12-hydroxy Oleic 12-hydroxy Oleic Acids Acid 9-Octadecenoic Acids Octadecenoic 9-Octadecenoic Acid 9 Octadecenoic Acid Octadecenoic Acids Acids Ricinoleic Ricinoleic Acids Acids Oleic Oleic Acids Acid Oleic Oleic Acid Oleate 5.419668508287
10007823 Oleoyl Ethanolamide-d2 - ≥99% deuterated product 2006-03-06 13.068480662984 oleoyl-ethanolamide-d2 OEA-d2; Oleic Acid Ethanolamide-d2 GC/MS deuteriums isotopes internal standards deuterateds LC/MS GC-MS LC-MS mass spectrometry cannabinoids neurotransmitter chocolate fatty acids neurochemistry neuroscience ethanolamines ethanolamides cbs synthetic 13.068480662984
9000552 Oleoyl Ethanolamide-d4 Exclusive - ≥99% deuterated product ✓ 2010-01-12 10.002320441988 oleoyl-ethanolamide-d4 Oleic Acid Ethanolamide-d4; OEA-d4 cannabinoids neurotransmitter chocolate fatty acids neurochemistry neuroscience ethanolamines ethanolamides deuterateds deuteriums MS mass spectrometry CBs LC-MS OEAs LC/MS GC/MS G-MS standards PPAR brain tissue neurochemistry neuroscience synthetic 10.002320441988
9000694 Oleoyl Serotonin-d17 Exclusive - ≥99% deuterated product ✓ 2010-09-27 5.120520915548 oleoyl-serotonin-d17 N-arachidonoyl serotonin AA-5-HT AA-5HT antagonists fatty acids amide hydrolase FAAH transient receptors potential vanilloid-type 1 channels TRPV1 pain capsaicin ethanolamine anandamide AEA deuterateds deuteriums MS mass spectrometry GC-MS LC-MS GC/MS LC/MS standards 5.120520915548
360900 PAF C-16-d4 - ≥99% deuterated product 22.865635359116 paf-c-16-d4 Platelet-activating Factor C-16-d4 PAFs deuterium GC/MS internal isotopes deuterated PAF-C-16-d4 standards GC-MS LC/MS LC-MS mass spectrometry platelet-activating factors atherosclerosis 22.865635359116
10010229 PAF C-18 -d4 Exclusive - ≥99% deuterated product ✓ 2010-11-03 11.223171270718 paf-c-18-d4 PAFs platelet-activating factors atherosclerosis deuterateds deuterium mass spectrometry MS LC/MS GC/MS LC-MS GC-MS 11.223171270718
9000431 Palmitoleic Acid-d14 Exclusive - ≥99% deuterated product ✓ 2009-12-04 5.214972375690 palmitoleic-acid-d14 deuteriums GC/MS internal isotopes standards LC/MS mass spectrometry fatty acids deuterateds GC-MS LC-MS MS 5.214972375690
10007824 Palmitoyl Ethanolamide-d4 Exclusive 1159908-45-8 ≥99% deuterated product ✓ 2006-03-06 30.176906077348 palmitoyl-ethanolamide-d4 Palmidrol-d4; PEA-7,7,8,8-d4 GC/MS deuteriums isotopes internal standards deuterateds LC/MS GC-MS LC-MS mass spectrometry neurochemistry neuroscience endocannabinoids CB2 neurotransmitters receptors ligands PEA N-(2-hydroxyethyl)-hexadecanamide cyclic cAMP ethanolamides anandamides AEA fatty acids neurochemistry ethanolamines cannabinoids cbs synthetic 30.176906077348
9000551 Palmitoyl Ethanolamide-d4 Exclusive - ≥99% deuterated product ✓ 2010-01-20 8.388955538015 palmitoyl-ethanolamide-d4 Palmidrol-d4; PEA-hydroxyethyl-1,1,2,2-d4 endocannabinoids CB2 neurotransmitters receptors ligands PEAs N-(2-hydroxyethyl)-hexadecanamide cAMP ethanolamides anandamides AEA fatty acids neurochemistry neuroscience ethanolamines LC-MS GC-MS mass spetrometry standards deuterateds deuterium MS LC/MS GC/MS cannabinoids cbs synthetic 8.388955538015
9000573 Palmitoyl Ethanolamide-d5 Exclusive - ≥99% deuterated compound ✓ 2010-03-04 5.932974217311 palmitoyl-ethanolamide-d5 PEA-15,15,16,16,16-d5; Palmidrol-d5 endocannabinoids CB2 neurotransmitters receptors ligands PEA N-(2-hydroxyethyl)-hexadecanamide cAMP ethanolamides anandamides AEA fatty acids neurochemistry neuroscience ethanolamines LC-MS GC-MS mass spetrometry standards deuterateds deuterium MS LC/MS GC/MS CBs synthetic 5.932974217311
310210 Prostaglandin A2-d4 - ≥99% deuterated product 2.975046040515 prostaglandin-a2-d4 Medullin-d4; PGA2-d4 GC/MS deuterium isotopes PGA2-d4 internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry neuroscience 2.975046040515
10007199 Prostaglandin A2 Lipid Maps MS Standard - ≥98% 2008-07-01 3.448539857932 prostaglandin-a2-lipid-maps-ms-standard Medullin; PGA2 PGA2 prostaglandins vasodilation mass spectrometry 3.448539857932
311210 Prostaglandin B2-d4 - ≥99% deuterated product 17.886243093922 prostaglandin-b2-d4 PGB2-d4 GC/MS deuterium isotopes PGB2-d4 internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry 17.886243093922
10007201 Prostaglandin B2 Lipid Maps MS Standard 13367-85-6 >99% 2008-10-24 38.601289134438 prostaglandin-b2-lipid-maps-ms-standard PGB2 PGB2 prostaglandins vasodilation mass spectrometry GC LC MS standards 38.601289134438
312000 Prostaglandin D1-d4 - ≥99% deuterated product 0.587918968692 prostaglandin-d1-d4 PGD1-d4 GC/MS deuterium isotopes PGD1-d4 internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry 0.587918968692
312010 Prostaglandin D2-d4 - ≥99% deuterated product 55.610165745856 prostaglandin-d2-d4 PGD2-d4 GC/MS deuterium isotopes PGD2-d4 internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry neurochemistry neuroscience 55.610165745856
10007272 Prostaglandin D2-d4 Lipid Maps MS Standard - ≥99% deuterated compound 2009-02-26 47.598011049723 prostaglandin-d2-d4-lipid-maps-ms-standard PGD2-d4 GC/MS deuterium isotopes PGD2-d4 internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry neurochemistry neuroscience MS mass spectrometry standards 47.598011049723
10010123 Prostaglandin D2-d9 - ≥99% deuterated product 2007-10-25 93.132005831798 prostaglandin-d2-d9 PGD2-d9 GC/MS deuterium isotopes internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry neurochemistry neuroscience allergy asthma 93.132005831798
10007203 Prostaglandin D2 Ethanolamide Lipid Maps MS Standard 398138-28-8 >96% 2008-10-29 28.541617995264 prostaglandin-d2-ethanolamide-lipid-maps-ms-standard PGD2-EA anandamides ethanolamides cannabinoids PGD2 prostaglandins AEA neurochemistry neuroscience ethanolamines prostamides GC LC mass spectrometry MS standards 28.541617995264
10007202 Prostaglandin D2 Lipid Maps MS Standard 41598-07-6 >99% 2008-10-27 18.350641733956 prostaglandin-d2-lipid-maps-ms-standard PGD2 Vasodilation prostaglandins brain sleep platelets aggregation. H-PGDS synthases mast cells hematopoietic allergic allergy asthmatic anaphylaxis hypotension inhibits inhibitors inhibition beta-trace .beta.-trace b-trace neurochemistry mass spectrometry standards GC LC MS 18.350641733956
313010 Prostaglandin E1-d4 - ≥99% deuterated product 24.456611418048 prostaglandin-e1-d4 Alprostadil-d4; PGE1-d4 GC/MS deuterium isotopes PGE1-d4 internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry atherosclerosis 24.456611418048
314010 Prostaglandin E2-d4 - ≥99% deuterated product 75.793270718232 prostaglandin-e2-d4 Dinoprostone-d4; PGE2-d4 GC/MS deuterium isotopes PGE2-d4 internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry 75.793270718232
10007273 Prostaglandin E2-d4 Lipid Maps MS Standard - ≥99% deuterated product 2009-02-26 51.720033149171 prostaglandin-e2-d4-lipid-maps-ms-standard Dinoprostone-d4; PGE2-d4 GC/MS deuterium isotopes PGE2-d4 internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry MS mass spectrometry standards 51.720033149171
10581 Prostaglandin E2-d9 - ≥99% deuterated product 2010-09-16 95.288941068139 prostaglandin-e2-d9 PGE2-d9; Dinoprostone-d9 PGE2 metabolites EP1 EP2 EP3 EP4 prostaglandins pharma:2 deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS standards 95.288941068139
10007212 Prostaglandin E2 Ethanolamide Lipid Maps MS Standard 194935-38-1 >98% 2008-11-05 31.647041129527 prostaglandin-e2-ethanolamide-lipid-maps-ms-standard Dinoprostone Ethanolamide; Prostamide E2; PGE2-EA anandamides ethanolamides cannabinoids PGE2 prostaglandins AEA analogs neurochemistry neuroscience ethanolamines prostamides GC-MS GC/MS LC-MS LC/MS mass spectromatory standards 31.647041129527
10007211 Prostaglandin E2 Lipid Maps MS Standard 363-24-6 >99% 2008-11-05 16.598158379374 prostaglandin-e2-lipid-maps-ms-standard Dinoprostone; PGE2 PGE2 metabolites EP1 EP2 EP3 EP4 prostaglandins GC LC MS mass spectrometry standards GC/MS LC/MS GC-MS LC-MS 16.598158379374
10008665 Prostaglandin F1α-d9 - ≥99% deuterated product 2006-08-04 7.724198895027 prostaglandin-f1-d9 PGF1α-d9 GC/MS deuterium isotopes PGF1a-d4 PGF1alpha-d4 PGF1.alpha.-d9 internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry 7.724198895027
316010 Prostaglandin F2α-d4 34210-11-2 ≥99% deuterated product 30.461259668508 prostaglandin-f2-d4 Dinoprost-d4; PGF2α-d4 GC/MS deuterium isotopes PGF2a-d4 PGF2alpha-d4 PGF2.alpha.-d4 internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry prostaglandin f2a d4 30.461259668508
10007275 Prostaglandin F2α-d4 Lipid Maps MS Standard 34210-11-2 ≥99% deuterated product 2009-02-26 14.511204419889 prostaglandin-f2-d4-lipid-maps-ms-standard Dinoprost-d4; PGF2α-d4 GC/MS deuterium isotopes PGF2a-d4 PGF2alpha-d4 PGF2.alpha.-d4 internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry 14.511204419889
10008643 Prostaglandin F2α-d9 - ≥99% deuterated product 2006-08-04 37.177872314303 prostaglandin-f2-d9 Dinoprost-d9 GC/MS deuterium PGF2.alpha.-d9 PGF2alpha-d9 internal standards prostaglandins mass spectrometry LC/MS GC-MS LC-MS deuterated PGF2a-d9 37.177872314303
316013 Prostaglandin F2α Ethanolamide-d4 - ≥99% deuterated product 10.959005524862 prostaglandin-f2-ethanolamide-d4 PGF2α-EA-d4 ethanolamides cannabinoids prostaglandins PGF2.alpha. PGF2alpha anandamides AEA COX-2 cox2 cyclooxygenases pghs2 pghs-2 synthases synthase-2 deuterium deuterated neuroscience ethanolamines prostamides GC/MS GC-MS LC/MS LC-MS mass spectrometry 10.959005524862
10007222 Prostaglandin F2α Ethanolamide Lipid Maps MS Standard 353787-70-9 >99% 2008-12-08 16.623425414364 prostaglandin-f2-ethanolamide-lipid-maps-ms-standard PGF2α-EA; Dinoprost Ethanolamide ethanolamides cannabinoids prostaglandins PGF2.alpha. PGF2alpha anandamides AEA COX-2 cox2 cyclooxygenases pghs2 pghs-2 synthases synthase-2 neuroscience ethanolamines prostamides MS mass spectrometry 16.623425414364
10007221 Prostaglandin F2α Lipid Maps MS Standard 551-11-1 >99% 2008-12-13 42.374834254143 prostaglandin-f2-lipid-maps-ms-standard PGF2α; Dinoprost PGF2alpha PGF2.alpha. Lutalyse vasoconstriction bronchoconstriction prostaglandins endocrinology prostaglandin f2alpha f2 alpha MS Mass Spectrometry 42.374834254143
10007232 Prostaglandin F2β Lipid Maps MS Standard 4510-16-1 ≥99% 2009-02-03 4.664060773480 prostaglandin-f2-lipid-maps-ms-standard 9β-PGF2α; PGF2β prostaglandins MS mass spectrometry standards PGs inactive PGF2beta PGF2.beta. 4.664060773480
10007230 Prostaglandin G2 Lipid Maps MS Standard - >99% 2008-05-01 53.159208103131 prostaglandin-g2-lipid-maps-ms-standard PGG2 LMFA03010009 endoperoxides cyclooxygenases prostaglandins PGG2 cox-2 PGHS-1 PGHS-2 cox1 cox2 cox-1 synthases PGHS1 PGHS2 lipids mass spectrometry liquid gas chromatography LC- GC- standards 53.159208103131
10007231 Prostaglandin H2 Lipid Maps MS Standard - >99% 2008-05-01 41.660407458563 prostaglandin-h2-lipid-maps-ms-standard PGH2 LMFA03010010 PGH2 endoperoxides cyclooxygenase vasoconstrictors prostaglandins PGHS2 syntahses cox-2 cox2 PGHS-2 atherosclerosis lipids mass spectrometry liquid gas chromatography LC- GC- standards 41.660407458563
10007233 Prostaglandin J2 Lipid Maps MS Standard 60203-57-8 >95% 2009-01-05 34.108492501973 prostaglandin-j2-lipid-maps-ms-standard PGJ2 PGJ2 PGD2 metabolites PPARs prostaglandins peroxisome proliferator-activated receptors MS mass spectrometry standards PGs 34.108492501973
10007236 Prostaglandin K2 Lipid Maps MS Standard - ≥98% 2009-01-16 89.978867403315 prostaglandin-k2-lipid-maps-ms-standard PGK2 PGK2 9,11-diketones prostaglandins PGE2 PGD2 PGs MS mass spectrometry standards 89.978867403315
9000305 PtdIns-(1-arachidonoyl, 2-arachidonoyl-d8) (ammonium salt) Exclusive - ≥95% ✓ 2009-04-20 12.726546961325 ptdins-1-arachidonoyl-2-arachidonoyl-d8-ammonium-salt arachidonic acids deuterium atoms AA GC/MS LC/MS mass spectrometry deuterateds 12.726546961325
9000304 PtdIns-(1-arachidonoyl-d8, 2-arachidonoyl) (sodium salt) Exclusive - ≥95% ✓ 2009-06-29 0E-12 ptdins-1-arachidonoyl-d8-2-arachidonoyl-sodium-salt arachidonic acids deuterium deuterated phosphatidylinositol internal standards phosphates deuterium GC/MS standards GC-MS LC/MS LC-MS mass spectrometry 0E-12
9000414 PtdIns-(3,4,5)-P3 (1,2-dipalmitoyl)-d62 (sodium salt) Exclusive - ≥98% ✓ 2009-09-25 12.445123246918 ptdins-3-4-5-p3-1-2-dipalmitoyl-d62-sodium-salt Phosphatidylinositol-3,4,5-trisphosphate C-16-d62 (sodium salt); DPPI-3,4,5-P3-d62 (sodium salt) phosphatidylinositols triphosphates cellular signals signalling transduction phospholipids PIPs phosphatidylinositols triphosphates phospholipases PLC PLD analogs deuterium GC/MS internal isotopes standards GC-MS LC/MS LC-MS mass spectrometry deuterated diacyl glycerols DAG PIP3 mono di 12.445123246918
10005616 PtdIns-(3)-P1 (1,2-dipalmitoyl)-d62 (ammonium salt) - ≥99% deuterated product 2005-12-30 11.717010859210 ptdins-3-p1-1-2-dipalmitoyl-d62-ammonium-salt DPPI-3-P-d62 (ammonium salt); Phosphatidylinositol-3-phosphate C16-d62 (ammonium salt) phosphatidylinositols triphosphates cellular signals signalling transduction phospholipids phospholipases PLC PLD analogs deuterium GC/MS internal isotopes standards GC-MS LC/MS LC-MS mass spectrometry deuterated diacyl glycerols DAG PIP1 triphosphates mono 11.717010859210
10005615 PtdIns-(4,5)-P2 (1,2-dipamitoyl)-d62 (sodium salt) - ≥99% deuterated product 2006-01-30 12.430694857628 ptdins-4-5-p2-1-2-dipamitoyl-d62-sodium-salt Phosphatidylinositol-4,5-diphosphate C16-d62 (sodium salt); DPPI-4,5-P2-d62 (sodium salt) phosphatidylinositols triphosphates cellular signals signalling transduction phospholipids phospholipases PLC PLD analogs deuterium GC/MS internal isotopes standards GC-MS LC/MS LC-MS mass spectrometry deuterated diacyl glycerols DAG PIP2 triphosphates mono di 12.430694857628
10534 (R)-Bromoenol lactone-d7 Exclusive - ≥99% deuterated product ✓ 2010-06-17 4.669745856353 -r-bromoenol-lactone-d7 (R)-BEL-d7 selective iPLA2 inhibitors phospholipases PLAs BEL iPLA2b iPLA2.beta. iPLA2g iPLA2.gamma. lipids hydrolases cells signaling digestion membrane remodeling venom calcium independent releases AA arachidonic acids physiologic stimuli irreversible chiral mechanism-based human recombinants deuterium deuterateds GC/MS LC/MS LC-MS GC-MS mass spectrometry MS signalling standards 4.669745856353
10513 RCS-4-d9 New - ≥99% deuterated product 2011-09-12 44.447019892911 rcs-4-d9 cannabinoids receptors JWHs 018 CB1 CB2 cannabimimetics forensics sciences CBs neurochemistry synthetic standards deuterated deuterium mass spectrometry LC-MS LC/MS GC-MS GC/MS MS 44.447019892911
10010662 Rilmenidine-d4 85047-14-9 ≥99% deuterated product 2009-04-17 0.440193370165 rilmenidine-d4 adrenergic agonist agents antihypertensive deuterateds deuteriums standards GC/MS LC/MS GC-MS LC-MS mass spectrometry 0.440193370165
10010664 Ropinirole-d7 (hydrochloride) - ≥99% deuterated product 2009-06-30 0E-12 ropinirole-d7-hydrochloride deuterateds deuteriums standards GC/MS LC/MS GC-MS LC-MS mass spectrometry non-ergoline nonergoline dopamines agonist Parkinson's disease Parkinsons restless legs syndrome 0E-12
9000372 S-Adenosylhomocysteine-d4 Exclusive - ≥99% deuterated product ✓ 2009-12-02 18.445248618784 s-adenosylhomocysteine-d4 SAH-d4 deuteriums GC/MS LC/MS mass spectrometry GC-MS LC-MS deuterateds amino acids derivative cysteine methyl cycle biosynthesis 979-92-0 risk factors s-adenosyl-l-homocysteine-d4 18.445248618784
10535 (S)-Bromoenol lactone-d7 Exclusive - ≥99% deuterated product ✓ 2010-06-17 5.362784530386 -s-bromoenol-lactone-d7 (S)-BEL-d7 selective iPLA2 inhibitors phospholipases PLAs BEL iPLA2b iPLA2.beta. iPLA2g iPLA2.gamma. lipids hydrolases cells signaling digestion membrane remodeling venom calcium independent releases AA arachidonic acids physiologic stimuli irreversible chiral mechanism-based vasopression-induced rat aortic smooth muscle A10 deuterium deuterateds GC/MS GC-MS LC/MS LC-MS mass spectrometry MS signalling standards 5.362784530386
13830 Synthetic Cannabinoid HPLC Mixture I - ≥95% for each compound 2010-05-13 39.243082614455 synthetic-cannabinoid-hplc-mixture-i cannabinoids CBs endocannabinoids cannabidiols CP-47,497 cp 47,497 47,497-c8-homolog CP-47,497-C8 homolog analog CP-55,940 cp47,497 cp55,940 cp 55,940 HU-331 HU331 HU 331 HU308 HU 308 HU-308 JWH-015 jwh015 jwh 015 jwh 018 jwh018JWH-018 JWH-200 jwh200 jwh 200 jwh 250 jwh250 JWH-019 Win-55212-2 Jwh-250 win 55212-2 win55212 2 synthetic spices mixes synthetic 39.243082614455
13850 Synthetic Cannabinoid HPLC Mixture II - ≥95% for each compound 2010-12-21 39.551017802333 synthetic-cannabinoid-hplc-mixture-ii cannabinoids CBs synthetics mixtures receptors agonists synthetic 39.551017802333
11337 Synthetic Cannabinoid HPLC Mixture V (AM Series) New - ≥95% for each compound 2012-02-02 101.640890116636 synthetic-cannabinoid-hplc-mixture-v-am-series AM series AM-2201 AM-1220 AM-630 AM-1241 AM-694 AM-2233 AM2201 AM1220 AM630 AM1241 AM694 CBs cannbinoids mixtures AM2233 101.640890116636
10009039 tetranor-PGDM-d6 Exclusive - ≥99% deuterated product ✓ 2007-06-28 57.067671963972 tetranor-pgdm-d6 tetranor-Prostaglandin D Metabolite-d6 deuterated deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry PGD-M 57.067671963972
314840 tetranor-PGEM-d6 Exclusive - ≥99% deuterated product ✓ 82.235177335365 tetranor-pgem-d6 tetranor-Prostaglandin E Metabolite-d6 GC/MS deuterium isotopes tetranor-PGEM-d6 internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry metabolites urinary markers PGE-M 82.235177335365
10007216 tetranor-PGEM Lipid Maps MS Standard 24769-56-0 ≥98% 2008-12-13 61.738353591159 tetranor-pgem-lipid-maps-ms-standard tetranor-Prostaglandin E Metabolite metabolites urinary markers PGE1 PGE2 urine metabolites MS mass spectrometry standards PGE-M 61.738353591159
10007228 tetranor-PGFM Lipid Maps MS Standard 23109-94-6 >98% 2008-12-18 25.066505524861 tetranor-pgfm-lipid-maps-ms-standard tetranor-Prostaglandin F Metabolite metabolites PGF2alpha PGF2.alpha. urinary urine markers PGF2α MS mass spectrometry standards PGF-M 25.066505524861
319030 Thromboxane B2-d4 - ≥99% deuterated product 27.777403314917 thromboxane-b2-d4 TXB2-d4 GC/MS deuterium isotopes internal standards GC-MS LC/MS LC-MS mass spectrometry atherosclerosis prostaglandins TXB2-d4 thromboxanes deuterated 27.777403314917
10007237 Thromboxane B2 Lipid Maps MS Standard 54397-85-2 ≥99% 2009-01-16 17.096325966851 thromboxane-b2-lipid-maps-ms-standard TXB2 thromboxanes platelets metabolites TXB2 intrarenal TXA2 urine urinary atherosclerosis MS mass spectrometry standards 17.096325966851
13130 trans-Resveratrol-d4 - ≥99% deuterated product 2009-01-14 18.699378453038 trans-resveratrol-d4 (E)-Resveratrol-d4 selective cyclooxygenases inhibitors COX-1 PGHS-1 COX1 PGHS1 prostaglandins H synthases 1 antioxidants oxidative injury stress atherosclerosis deuterated LC/MS GC-MS LC-MS mass spectrometry deuterium sirtuins AHR antagonists aryl hydrocarbon receptors 18.699378453038
13129 trans-trismethoxy Resveratrol-d4 - ≥99% deuterated product 2009-02-09 17.114249539594 trans-trismethoxy-resveratrol-d4 (E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzene diol-d4 deuterated deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometrysirtuins AHR antagonists aryl hydrocarbon receptors 17.114249539594
10010652 Zolpidem-d6 - ≥99% deuterated product 2009-04-17 0E-12 zolpidem-d6 SL 80-0750-d6 insomia GABA gamma-aminobutyric acids receptors nonbenzodiazepine hypnotic deuterateds deuteriums standards GC/MS LC/MS GC-MS LC-MS mass spectrometry 0E-12
9000433 α-Linolenic Acid-d14 - ≥99% deuterated product 2010-09-13 7.645997544506 -linolenic-acid-d14 ALA-d14 fatty acids PUFAs omega-3 ω-3 polyunsaturated essential leafy green vegetables deuterium deuterateds GC/MS GC-MS LC/MS LC-MS mass spectrometry MS signalling standards alpha-linolenic α-linolenic signaling ALAS α-linolenic 7.645997544506
10007234 Δ12-Prostaglandin J2 Lipid Maps MS Standard 87893-54-7 ≥98% 2009-01-20 58.310709023941 -12-prostaglandin-j2-lipid-maps-ms-standard Δ12-PGJ2 delta12-PGJ2 d12-PGJ2 Δ12-PGJ2 antitumor antimitotic PPARgamma PPARγ PPARs peroxisome proliferator-activated receptors prostaglandins ligands MS mass spectrometry standards PGs anti-tumor 58.310709023941
390011 ω-3 Arachidonic Acid-d8 - ≥99% deuterated product 46.106441988950 -3-arachidonic-acid-d8 w-3-AA-d8 GC/MS GC-MS LC/MS LC-MS mass spectrometry deuterium internal isotopes standards deuterated .omega.-3-AA-d8 omega-3-AA-d8 w-3-arachidonic .omega.-3-arachidonic omega-3-arachidonic fatty acids PUFAs polyunsaturated 46.106441988950
Other Resources
Management Team Company Profile Company History ChemAssistant Tools FAQs Cayman Europe Cayman Pharma CaBRI Cayman Gear Press Releases Illustrations and Charts Key Research Area Posters Article Library Analysis Tools Conference Schedule Order Terms Browser Recommendation Privacy Statement Site Map

Cayman Chemical Company · 1180 East Ellsworth Road · Ann Arbor, Michigan 48108 · USA

Toll Free: (800) 364-9897 (USA and Canada Only) · Fax: (734) 971-3640

Copyright 2012 Cayman Chemical Company

Lost password?